Strategic and tactical approaches to the synthesis of 5,6-dihydro-[1,2,4]oxadiazines

Article abstract of DOI:10.3987/COM-16-13570

Three methods were developed for the synthesis of substituted 5,6-dihydro-4H-[1,2,4]oxadiazines. The desired oxadiazine rings were synthesised via reductive amination, addition to an iminium ion intermediate and by condensation of a diamine with an imidate. For all methods the scope with respect to the substituents that could be introduced was explored. It was found that the imidate condensation route was the most versatile and the products could be isolated in yields up to 91%. This route is also suitable for the introduction of chirality on the C5 and C6 position of the oxadiazine rings.

Full text of DOI:10.3987/COM-16-13570

2166
HETEROCYCLES, Vol. 92, No. 12, 2016
HETEROCYCLES, Vol. 92, No. 12, 216, pp. 2166 - 2200. © 2016 The Japan Institute of Heterocyclic Chemistry
Received, 1st September, 2016, Accepted, 21st October, 2016, Published online, 10th November, 2016
DOI: 10.3987/COM-16-13570
STRATEGIC AND TACTICAL APPROACHES TO THE SYNTHESIS OF
5,6-DIHYDRO-[1,2,4]OXADIAZINES
1
1
1
3
Johan J. N. Veerman, * Yorik B. Bruseker, Bart C. J. van Esseveldt,
2
3
1
Rebecca Glen, Bryce A. Harrison, Erik H. Heijne, Andrew J. McRiner,
1
1
1
Tommi M. Meulemans, Peter van Rijnsbergen, Wim Zonneveld, Matthew
3
*
3
G. Bursavich, and Duane A. Burnett
1Mercachem BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands.
2Peakdale Molecular Ltd, Sheffield Road, Chapel-en-le-Frith, High Peak, SK23
3
0
PG, UK. FORUM Pharmaceuticals, 225 Second Avenue, Waltham MA 02451,
USA
E-mail: johan.veerman@mercachem.com; matt.bursavich@morphicrock.com
Abstract – Three methods were developed for the synthesis of substituted
5,6-dihydro-4H-[1,2,4]oxadiazines. The desired oxadiazine rings were synthesised
via reductive amination, addition to an iminium ion intermediate and by
condensation of a diamine with an imidate. For all methods the scope with respect
to the substituents that could be introduced was explored. It was found that the
imidate condensation route was the most versatile and the products could be
isolated in yields up to 91%. This route is also suitable for the introduction of
chirality on the C5 and C6 position of the oxadiazine rings.
INTRODUCTION
Small heterocycles are important structures in pharmaceuticals and other bioactive compounds, as they
provide a central scaffold around which substituents can be placed in a well-defined manner to probe the
1
biological activity. Therefore, the development of efficient and general methodology to access these
2
heterocyclic scaffolds is an important endeavour. As part of a medicinal chemistry program, the synthesis
of 3,5-biaryl substituted 5,6-dihydro-4H-[1,2,4]oxadiazines was of interest. This heterocyclic scaffold has
an already established pharmaceutical relevance and is for example present in a non-ATP-competitive
3
MK2 inhibitor (1, Figure 1) to treat inflammatory diseases such as arthritis. In addition, it has been used as
4
a central scaffold in a lead compound for the treatment of Alzheimer’s disease (2) and in BRX-235
(
Iroxanadine, 3), a drug which acts as a potent cardioprotective agent.5

HETEROCYCLES, Vol. 92, No. 12, 2016
2167
Figure 1. Examples of 1,2,4-oxadiazines in pharmaceuticals
A
survey of the literature reveals
a
few early examples on the synthesis of
6
5
,6-dihydro-4H-[1,2,4]oxadiazines. However, to the best of our knowledge, the first report in this field
7
was contributed by Rajagopalan and Talaty. They developed a two-step procedure in which an
1-aroylaziridine oxime undergoes ring-opening by hydrochloric acid, followed by a cyclization of the
intermediate chloride under alkaline conditions. This strategy proved to be a useful synthetic method and
was further elaborated by other groups.8, 9 A modification of this approach was reported by Cho et al. who
used the Lewis acid scandium(III) triflate in combination with chlorotrimethylsilane to promote ring
opening and cyclization of aziridin-1-yl oximes to 5,6-dihydro-4H-[1,2,4]oxadiazines.10 Tabei and
co-workers
reported
the
synthesis
of
a
mixture
of
geometrical
isomers
of
3-aryl-5-ethoxycarbonylmethylene-5,6-dihydro-4H-[1,2,4]oxadiazine derivatives via reaction of
1
1
benzamide oximes with bromoacetoacetyl bromides. Other approaches involve the reaction of aliphatic
nitro compounds and acetyl chloride with β-diketones leading to tri-substituted [1,2,4]oxadiazine
derivatives12
-aryl-trans-5,6-dihydroxy-5,6-dihydro-4H-[1,2,4]oxadiazines. More recent examples for the synthesis
and the condensation of
benzamidoximes with
glyoxal
to
furnish
13
3
of the oxadiazine scaffold include ring expansion of fluorooxazolines with hydroxylamine hydrochloride,14
and cyclo-condensation reaction of mesoionic 4-trifluoroacetyl-1,3-oxazolium-5-olates with
hydroxylamine.15
For our purposes we needed an approach where the substituent on the 5 position could be selectively
introduced and easily modified. Based on a retrosynthetic analysis, three routes to the target oxadiazines
were devised (Scheme 1).

2168
HETEROCYCLES, Vol. 92, No. 12, 2016
Scheme 1. Retrosynthetic approach to oxadiazines
The first route comprises a novel intramolecular reductive amination. The second route features a
nucleophilic addition onto an in situ generated iminium ion. Additions to (N-acyl)iminium ions are well
1
6
precedented in literature, but there are no known examples on an oxadiazine system. The third route is
based on the condensation of an appropriate diamine onto an imidate building block. There are a few
examples known for this type of cyclisation in literature, but only for simple diamines.17 As we
these methods to be suitable for the introduction of a variety of R groups as well as the synthesis of chiral
derivatives, the scope of these approaches was explored.
RESULTS AND DISCUSSION
First, the reductive amination approach was investigated (Table 1). Hydroxybenzimidamide 4 was
alkylated with bromoacetophenone using sodium hydride in DMF to generate intermediate 5a. Analysis
of the reaction mixture by LCMS showed full consumption of 4 and formation of two products with
1
correct mass. Analysis of the crude product by H NMR showed this to be a mixture of 5a and the
corresponding cyclic aminal 5’a in a 9:1 ratio. Attempts to isolate the intermediates by column
chromatography were problematic, as the compounds co-eluted. Furthermore, only a low yield (25%) of
the mixture 5a/5a’ was recovered after column chromatography, indicating the product to be instable on
silica. Therefore, the crude mixture of the alkylation reaction was used in the subsequent reduction step
and the yield was determined over the two steps.

HETEROCYCLES, Vol. 92, No. 12, 2016
2169
Table 1. Synthesis of 5-substituted 3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazines via reductive
amination
Alkylation
conditions
Reductive amination
conditions
entry
R
product Yield (%)a
NaH, DMF,
°C to rt, 1 h (A)
NaBH
rt, 16 h
NaBH(OAc)
MeOH, 60 °C, 3 h
NaBH(OAc) , TFA,
DCE, rt to 40 °C, 20 h
AcOH/MeOH, 60 °C,
4
, MeOH,
1
2
3
Ph
Ph
Ph
6a
6a
6a
0
0
0
3
, AcOH/
A
A
3
traces
4
Ph
A
1 h, then NaBH
3
CN,
6a
35
6
0 °C, 3 h (B)
K
2
CO
rt to 60 °C, 3 h
Cs CO , DMF,
0 °C, 3 h
3
, MeOH,
5
6
7
Ph
Ph
Ph
Ph
B
B
B
B
6a
6a
6a
6a
0
2
3
15
16
57
6
K
2
CO , acetone,
3
rt to 60 °C, 3 h
PS-BEMP,
8
9
MeCN, rt, 2 h (C)
4-MeOPh
4-ClPh
C
C
C
C
C
C
B
B
B
B
B
B
B
6b
6c
6d
6e
6f
40
0
12
51
43
0
1
1
1
1
1
1
0
1
2
3
4
5
b
Me
chex
tBu
CO
2
Me
6g
6h
4-pyridyl
C
0
a
b
Isolated yield over two steps. Chloroacetone was used in the alkylation.
The reduction of crude 5a/5’a using NaBH
4
in MeOH failed and only starting material was observed
in acetic acid/methanol also failed with mainly
decomposition observed (entry 2). Treatment with NaBH(OAc) in DCE with TFA as additive showed
traces of product formation, but the reaction did not go to completion. Additionally, reduction of the
(Table 1, entry 1). The reduction using NaBH(OAc)
3
3

2170
HETEROCYCLES, Vol. 92, No. 12, 2016
ketone of 5a to the corresponding alcohol was observed by LCMS (entry 3). As the cyclisation to the
imine/aminal intermediate appeared to be the problem and to prevent reduction of ketone 5a, the mixture
of 5a/5’a was first heated in MeOH/AcOH to induce cyclisation. After heating at 60 °C for 1 hour, full
conversion into a mixture of the corresponding imine/methoxyaminal was observed by LCMS. Addition
of NaBH
3
CN to the mixture afforded the product 6a in 35% yield over the two steps (entry 4).
CN for NaBH(OAc) or NaBH under the same conditions gave lower yields.
Substitution of NaBH
3
3
4
Despite the low yield, all the intermediate formed in the alkylation was converted into the product
according to LCMS analysis, so the alkylation reaction was investigated in more detail. In order to assess
the alkylation, the crude product from the alkylation reaction was converted into 6a using conditions B
and the overall yield over two steps was determined. A first test with K
formation of many undesired products as observed by LCMS (entry 5). The alkylation with Cs
DMF proceeded somewhat better, although elevated temperature was needed and 6a was isolated in low
yield (entry 6). The use of K CO in acetone afforded 6a in a similar yield of 16% (entry 7). Finally,
polystyrene supported 2-tert-butylimino-2-diethylimino-1,3-dimethylperhydro-1,3,2-diazaphosphorine
PS-BEMP) was used as the base (entry 8). A fast and fairly clean reaction was observed by LCMS at
2
CO
3
in methanol failed with the
2
CO in
3
2
3
(
room temperature and the intermediate mixture 5a/5’a was conveniently isolated after filtration of the
base and concentration. Upon reductive amination 6a was isolated in a reasonable 57% yield over the two
steps. The conditions in entry 8 were used in the subsequent reactions to determine the scope of this
procedure. The 4-methoxyphenyl derivative 6b was synthesised in 40% yield (entry 9), but introduction
of an electron withdrawing 4-chlorophenyl group to obtain 6c failed completely (entry 10), which was
caused by a failed alkylation reaction as the intermediates 5c/5’c were not be observed by LCMS.
Introduction of a methyl (entry 11), cyclohexyl (entry 12) or tBu (entry 13) group afforded the products
6
d, 6e and 6f in 12%, 51% and 43% yields, respectively. Finally, introduction of an ester (entry 14) or a
4-pyridyl group (entry 15) was attempted, but the products could not be isolated. In the ester case some
alkylation was observed, but the reduction failed. In the pyridine case, the alkylation did not work and the
intermediates 5h/5’h were not observed. Although this route gave access to a number of oxadiazine
derivatives, the yields were not very high. Moreover, both the alkylation and reductive amination
conditions seem to be substrate specific, hampering easy analogue generation. The low yield in the
alkylation might be due to a proton transfer of the halo ketone to deprotonated 4, resulting in a poor
alkylation/side product formation. This would match the trend observed in the examples above, as the
more easily enolisable halo ketones give lower yields or no reaction at all.
To check this hypothesis, an alternative route was devised, where an allyl group was introduced as a
masked ketone (Table 2). First, hydroxybenzimidamide 4 was alkylated with 3-bromo-2-methylpropene
allyl bromide to afford alkene 8d in 81% yield. In this case, NaH/DMF afforded the product in higher

HETEROCYCLES, Vol. 92, No. 12, 2016
2171
Table 2. Synthesis of 5-substituted 3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazines via alkene
oxidation/reductive amination
Suzuki reaction
Oxidation/reduction
entry
R
product
product
a
b
yield (%)
yield (%)
1
2
3
4
5
6
7
8
9
Me
Ph
4-MeOPh
4-MePh
4-ClPh
4-FPh
-
8d
8a
8b
8i
8c
8j
8k
8l
8m
8n
8o
57
80
59
68
66
71
75
66
38
0
6d
6a
6b
6i
6c
6j
6k
6l
6m
6n
6o
72
61
60
63
61
62
c
3-MeOPh
3-ClPh
3-benzofuran
2-(N-Me-indole)
3-pyridyl
c
55
66
97
62
1
1
0
1
22
a
b
Isolated yield, reactions were monitored by LCMS and stopped as soon as full conversion was observed.
Isolated yield over two steps. Reaction performed at 70 °C using 1.1 equiv. of boronic acid.
c
yield than PS-BEMP in acetonitrile. Next, the double bond was converted into the ketone using
1
8
OsO
4
/NaIO . Clean conversion was observed by LCMS and the crude product (100% yield) was used
4
directly in the reductive amination to provide 6d in 57% yield over two steps (entry 1). This approach
indeed confirmed that the problem is the alkylation step and not the reduction, as the initial procedure
afforded the product in only 12% yield. In order to synthesize derivatives, 4 was alkylated with
2,3-dibromoprop-1-ene affording building block 7 in 75% yield. The introduction of a phenyl group was

2172
HETEROCYCLES, Vol. 92, No. 12, 2016
effected by a Suzuki reaction to afford 8a in an acceptable 72% yield. The double bond was oxidised to
afford the intermediate mixture 5a/5a’ (see Table 1) in quantitative yield. Subsequent purification by
column chromatography again led to partial decomposition resulting in an isolated yield of only 30%. As
expected, direct reduction of the crude intermediate afforded 6a in 80% yield (entry 2). Although this
route is one step longer, it does give access to additional targets as a plethora of R groups can be
introduced by palladium catalysis. To explore the scope, a few simple phenyl derivatives with electron
donating and withdrawing groups were synthesized. The substituent at the 4-position of the phenyl ring
did not have much influence on the Suzuki reaction as the introduction of a 4-methoxy-, 4-methyl-,
4-chloro- and 4-fluorophenyl proceeded in similar yields of 60–63% (entries 3–6, products 8b, 8i, 8c and
8
j, respectively). For the 4-chloro derivative 8c, however, the Suzuki reaction was run at 70 °C using 1.1
equivalent of boronic acid to prevent the formation of oligomers (entry 5). Gratifyingly, the subsequent
oxidations/reductive aminations proceeded in 59–71% yields, now allowing access to electron poor
aromatic substituents as well. The introduction of a 3-methoxy- and 3-chlorophenyl afforded alkenes 8k
(entry 7) and 8l (entry 8) in 62% and 55% yield, respectively. Subsequent oxidation/reduction afforded
the corresponding oxadiazines 6k and 6l in 75% and 66% yield, respectively. Next, the introduction of
heteroaryls was tested. Introduction of a 3-benzofuran gave the precursor 8m in 66% yield (entry 9). The
subsequent ketone formation gave clean conversion, but in the reductive amination several small
unidentified impurities formed, resulting in only 38% isolated yield of 6m. A 2-(N-methyl)indole was
introduced in almost quantitative yield (entry 10). While the conversion into the ketone proceeded
smoothly, the reductive amination failed to deliver the product. Several unidentified products formed and
after tedious purification, some over-reduced 6n (reduction of the indole to the indolinyl) was isolated in
1
9
1
2% yield. Finally, introduction of a pyridine was attempted and the Suzuki reaction afforded 8o in 62%
yield (entry 11). The oxidative cleavage to the ketone went slowly and took 16 hours to reach completion.
The subsequent reductive amination afforded product 6o in only 22% yield. The synthesis of the
corresponding 4-pyridyl derivative was also attempted, but failed as the synthesis of the intermediate
alkene by either Suzuki or Stille reaction did not work. This strategy provides an improvement over the
initial alkylation/reductive amination procedure, but still takes four steps and therefore a shorter approach
was investigated: the direct introduction of nucleophiles on the 5-position by nucleophilic attack on an
iminium ion intermediate (Table 3).

HETEROCYCLES, Vol. 92, No. 12, 2016
2173
Table 3. Synthesis of 5-substituted 3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazines via iminium ion
reactions
OEt
OEt
O
Br
OEt
KOH
N
OEt
OH
N
H SO
2 4
O
N
H
OEt
N
NH2
DMSO, rt, 18 h
77%
EtOH, 65 °C, 1 w
NH2
4
9
69%
10
formic acid,
00 °C, 15 min
(Lewis) acid
nucleophile
1
O
O
N
N
nucleophile
formic acid
N+
H
N
R
H
11
6b, i, l, p-y
starting
material
temp
(°C)
time
(h)
Yield
(%)
entry
nucleophile
R
product
d
a
1
2
3
4
5
6
7
8
10
9
9
9
9
9
9
9
furan
furan
indole
rt
rt
rt
rt
rt
100
100
100
20
20
20
20
84
2.5
4
2-(furan)
2-(furan)
3-(indole)
6p
6p
6q
6r
6s
92
88
70
86
87
53
69
74
20
67
trace
0
a
a
a
N-Me-indole
indazole
benzofuran
3-(N-Me-indole)
3-(indazole)
2-(benzofuran)
a
a
6t
a
benzo[b]thiophene
benzo[d][1,3]dioxole
2-(benzo[b]thiophene)
5-(benzo[d][1,3]dioxole)
6u
6v
6w
6b
6i
a
4.5
2
4
-(methoxyphenyl)
-(methoxyphenyl)
4-(methylphenyl)
3-(chlorobenzene)
allyl
9a
anisole
100
2.5
9
a
1
1
1
0
1
2
9
9
10
toluene
chlorobenzene
allylTMS
100
100
rt
21
21
20
a
b
6l
6x
64
trimethyl((1-phenyl-
vinyl)oxy)silane
2-(1-phenyl-
ethan-1-one)
1
3c
10
rt
48
6y
33
a
b
Reaction performed in formic acid using 5 equiv. of nucleophile. Reaction performed in DCM using 5
c
equiv. of nucleophile and 5 equiv. of BF
3
·OEt
2
. Reaction performed in DCM using 2.5 equiv. of
d
nucleophile and 0.1 equiv of Sc(OTf)
3
. Isolated yield.
In order to test Route 2, compound 4 was O-alkylated with bromoacetaldehyde diethyl acetal to afford
compound 9. Next, prolonged stirring with sulfuric acid in ethanol gave the cyclic ethoxy aminal 10 in
69% yield after column chromatography. The coupling of 10 with furan as the nucleophile in formic acid
afforded the product 6p in 92% yield (Table 3, entry 1). In order to shorten the route, intermediate 9 was
heated for 15 minutes in formic acid to generate the intermediate iminium ion 11 in situ. The mixture was

2174
HETEROCYCLES, Vol. 92, No. 12, 2016
cooled to room temperature and furan was added as the nucleophile again. Gratifyingly, product 6p was
isolated in similar yield of 88% (entry 2). Next, a set of (hetero)aromatic nucleophiles was added to
screen the scope of this reaction starting from 9. As expected, both indole (entry 3) and N-methyl-indole
(entry 4) could be coupled in good yields at room temperature to afford products 6q and 6r. Additionally,
indazole also reacted at room temperature to afford the product 6s in 87% yield (entry 5). The addition of
benzofuran (entry 6) required heating to afford the product 6t in 53% yield. Benzo[b]thiophene (entry 7)
was added in good yield as well resulting in the formation of 2-isomer 6u in 69% yield. Formation of
some additional regioisomers was also observed by LCMS, but these could not be isolated in pure form.
The coupling of benzo[d][1,3]dioxole afforded the product 6v in 74% yield as a single 5-isomer (entry 8).
As expected, anisole also reacted, leading to the formation of the 2- and 4-methoxy regioisomeric
products 6w and 6b in a 1:3.3 ratio in 87% overall yield (entry 9). The limit of this addition was reached
using toluene as the nucleophile (entry 10). A trace of product 6i was observed in the reaction mixture by
LCMS, but over time side product formation was observed. As expected, the reaction with the more
electron poor chlorobenzene to obtain 6l failed completely (entry 11). Next, the addition of some
non-aromatic nucleophiles was tested starting from 10 using BF
3
·OEt
2
as the Lewis acid in
dichloromethane, conditions commonly used in the coupling of nucleophiles with N-acyliminium ions.20
Introduction of an allyl unit was effected in 64% yield to afford product 6x (entry 12). Although there is
an electron withdrawing hydroxylimine group attached to the intermediate iminium ion, the reaction was
quite slow and needed 20 hours to reach completion. A reaction with the silyl enol ether of acetophenone
was initially tested with BF
3
·OEt as the Lewis acid. A rapid reaction was observed, but the initial
2
product reacted with the excess nucleophile resulting in the formation of oligomers. When Sc(OTf) was
3
used as the Lewis acid, the ketone 6y could be isolated in 33% yield.
Scheme 2. Synthesis of N-substituted 3-phenyl-5-furyl-5,6-dihydro-4H-[1,2,4]oxadiazines via iminium
ion reactions
Although the oxadiazines can be N-alkylated, the iminium ion reaction sequence was also tested for the
synthesis of N-substituted derivatives (Scheme 2). This way, the position of the N-alkyl group is

HETEROCYCLES, Vol. 92, No. 12, 2016
2175
unambiguous and it allows for the introduction of R groups that might be difficult to install afterwards.
Starting from intermediates 12a and 12b, the iminium ion precursors 13a and 13b were synthesized. The
subsequent introduction of a furan group did not proceed at room temperature as before with the
unsubstituted derivative 9, but required additional heating. The methyl derivative 14a was isolated in 58%
yield after heating for 4 hours at 70 °C. The phenyl derivative required heating overnight to provide
product 14b in 68% yield. Although giving access to a variety of 5-substituted oxadiazine targets, this
approach is limited to the use of electron rich nucleophiles and also does not give access to optically pure
derivatives. Therefore, the synthesis of a chiral diamine 16 was started to test the construction of
oxadiazines by condensation with an imidate (Scheme 3).
1
2
3
) HO-N(Phthal), PPh , DIAD,
THF, rt, 1 h, 93%
) hydrazine, EtOH, rt, 15 min, 80%
3
19a-d OEt
NH
AcOH, rt, 16 h
HCl
NH2
OH
R
O
HN
Boc
) HCl, EtOAc, rt, 1 h,
H N
2
then K CO , MeOH, rt, 1 h, 82%
2
3
15
16
O
N
O
HN
NH2
R
N
AcOH, 100 °C
H
R
NH
1
1
1
1
7a: R = Ph
7b: R = Me
7c: R = cHex
7d: R = 2-pyridyl
2 h
S-6a: 84%
S-18b: 82%
S-18c: 91%
S-18d: 85%
0
h
0
.5 h
2
h
Scheme 3. Synthesis of 5-phenyl 3-substituted-5,6-dihydro-4H-[1,2,4]oxadiazines via condensation of
diamines with imidates
The commercially available N-Boc-phenylglycinol 15 was converted into the diamine 16 in 3 steps. Next,
the diamine was stirred at room temperature overnight with ethyl benzimidate hydrochloride 19a leading
to intermediate 17a. Upon heating to 100 °C for 2 hours, intramolecular attack of the nitrogen onto the
imidate, followed by elimination of ammonia led to clean conversion into S-6a and the product was
isolated in 84% yield. The free amine must be used in the reaction, attempts to perform the cyclisation
reaction with the initially isolated dihydrochloride salt of 16 failed as the intermediate did not form.
Starting the reaction at 100 °C directly also afforded the product, but in lower yield. At higher
temperature the amine of the intermediate can react with a second equivalent of the imidate leading to
side product formation. Gratifyingly, chiral HPLC analysis showed no racemization had taken place in

2176
HETEROCYCLES, Vol. 92, No. 12, 2016
the synthesis of S-6a. Considering the number of (optically pure) amino alcohols/amino acids available,
this route gives access to an array of (optically pure) oxadiazines. As expected, variation on the 3 position
could easily be effected by changing the starting imidate. The methyl derivative S-18b already cyclised
by stirring at room temperature overnight in 82% yield. Both the cyclohexyl (S-18c) and 2-pyridyl
(S-18d) derivatives required some additional heating to give the products in 91% and 85% yield,
respectively.
Encouraged by these results, the scope with respect to the diamines that can be used in the cyclization was
explored using ethyl benzimidate hydrochloride 19a as the imidate (Table 4). The unsubstituted
oxadiazine derivative 21a was obtained in 63% yield (entry 1). Either a 4-, 5-, or 6-methyl group was
installed on the oxadiazine starting from the appropriate diamine to afford 21b (entry 2, 74%), 6d (entry 3,
77%) and 21d (entry 4, 57% yield), respectively. The somewhat lower yield for 21d was the result of
double addition of the diamine to the imidate, caused by the increased nucleophilicity of the N-methylated
amine. A [5-6] cis (21e, 53%, entry 5), or trans (21f, 71%, entry 6) annulated cyclohexyl ring was
installed on the oxadiazine in reasonable yields. A smaller [5-6] cis annulated cyclopentyl ring (21g, entry
7) could be introduced in 78% yield as well. As expected, the cyclization to the corresponding trans
annulated derivative 21h was more difficult (entry 8), but the product could be isolated in 25% yield after
heating for 48 hours. Introduction of a [4-5] annulated ring was also possible in high yield starting from
the prolinol derived diamine 20i to afford 21i in 80% yield (entry 9). Finally, introduction of a quaternary
center was probed. The 5,5-dimethyl substituted oxadiazine 21j was synthesized in 83% yield starting
from amine 20j (entry 10). Starting from diamine 20k, the spiro-fused oxadiazine 21k was synthesized in
87% yield (entry 11). Based on these results, the synthesis of a large number of substituted oxadiazines
can conveniently be accomplished starting from easily accessible diamines.
In summary, three approaches for the synthesis of substituted 5,6-dihydro-4H-[1,2,4]oxadiazines were
investigated. The first approach via alkylation with a haloketone, followed by reductive amination, gave
moderate to low yields. Additionally, the procedure was found to have a limited scope. These problems
could partly be alleviated by a multi-step approach involving alkylation with 2,3-dibromoprop-1-ene,
followed by introduction of R groups via a Suzuki reaction, oxidative cleavage of the double bond and
reductive ring closure. The direct introduction of substituents at the 5-position by addition to an iminium
ion provided new analogues in one synthetic step; however, the scope was limited to electron rich
nucleophiles. The condensation of a diamine with an imidate was found to be the most versatile route.
This route allowed for variation of substituents at the 3, 4, 5 and 6 position of the oxadiazine in good
yields. Furthermore, depending on the diamine used, optically pure oxadiazines could be prepared.

HETEROCYCLES, Vol. 92, No. 12, 2016
2177
Table 4. Synthesis of a series of 3-phenyl-substituted-5,6-dihydro-4H-[1,2,4]oxadiazines
a
The reaction mixtures were stirred at rt for 16 h to form the intermediate and then stirred at 100 °C for
b
the indicated time for the cyclisation. Isolated yield.

2178
HETEROCYCLES, Vol. 92, No. 12, 2016
EXPERIMENTAL
General Experimental Methods. All solvents and reagents were used as purchased from commercial
suppliers without further purification. Starting materials which were not commercially available were
synthesized by previously reported methods. Flash column chromatography was performed using
prepacked silica gel (20−40 mesh) columns. Analytical thin-layer chromatography was performed on
Merck 60 F254 glass plates. Visualization was accomplished with UV light, iodine, anisaldehyde or
potassium permanganate, followed by heating. Melting points were measured on a calibrated standard
1
melting point apparatus and are uncorrected. H NMR spectra were recorded in CDCl
3
or DMSO-d on a
6
300 or 400 MHz Bruker spectrometer and are reported in ppm using TMS (0.00 ppm) as an internal
1
3
standard. Proton-decoupled C NMR spectra were recorded on a 101 MHz Bruker spectrometer and are
reported in ppm using the internal solvent residual signal as an internal standard. Optical rotations were
measured in MeOH on a polarimeter with a 100 mm cell (c given in g/100 mL) operating at λ= 589 nm,
corresponding to the sodium D line, at the indicated temperatures. Basic preparative HPLC was
performed on a Reveleris Prep system: Detection: UV (220/254 nm), Column: XSelectTM CSH C18,
145x25 mm, particle size 10 Pm, Flow: 40 mL/min, Eluent A: 10 mM ammonium bicarbonate in water
pH = 9.0); Eluent B: 99% acetonitrile + 1% 10 mM ammonium bicarbonate in water; 5% B to 100% B
gradient. Acidic preparative HPLC was performed on a Reveleris Prep system: Detection: ELSD, UV 220
nm/254 nm), Column: Phenomenex Luna C18, 150x25 mm, particle size 10ꢀPm, Flow: 40 mL/min,
Eluent A: 0.1% (v/v) Formic acid in water, Eluent B: 0.1% (v/v) Formic acid in acetonitrile, 5% B to
100% B gradient. The product containing fractions were lyophilized to obtain the products.
General procedure A for the synthesis of 5-substituted 3-phenyl-5,6-dihydro-4H[1,2,4]oxadiazines via
alkylation and reductive amination. To a solution of N'-hydroxybenzimidamide 4 (250 mg, 1.84 mmol) in
MeCN (4 mL), PS-BEMP (2.2 mmol/g, 1.2 equiv, 1 g) was added. After stirring for 15 min at rt, the
bromo- or chloroketone (1.5 equiv.) in MeCN (2 mL) was added and the mixture was stirred for 2 h. The
solids were removed by filtration and the filtrate was concentrated to afford the crude alkylated
intermediate. This was dissolved in a mixture of MeOH (9 mL) and acetic acid (3 mL), heated to 60 °C
for 1 h, sodium cyanoborohydride (127 mg, 2.02 mmol, 1.1 equiv.) was added and the mixture was stirred
at 60 °C for an additional 3 h. The mixture was poured into an aqueous 1M NaOH solution (100 mL) and
extracted with EtOAc (2 x 50 mL). The combined organic layers were washed with brine, dried using
Na
2
SO and concentrated to afford the crude product, that was further purified as described.
4
3
,5-Diphenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6a). General procedure A was followed, using
2-bromo-1-phenylethan-1-one. Purification by silica flash column chromatography (30% EtOAc in
1
n-heptane) afforded compound 6a (254 mg, 57% yield) as a crystalline solid; mp 110 – 111 °C; H NMR

HETEROCYCLES, Vol. 92, No. 12, 2016
2179
(
400 MHz, CDCl ) δ 7.72 – 7.67 (m, 2H), 7.49 – 7.34 (m, 8H), 5.05 (s, 1H), 4.76 – 4.69 (m, 1H), 4.33 –
3
13
4
.23 (m, 1H), 3.76 (dd, J = 11.1, 7.4 Hz, 1H); C NMR (101 MHz, CDCl ) δ 152.9, 138.8, 130.5, 129.2,
3
1
28.9, 128.8, 127,0, 126.0, 77.5, 69.8, 54.4; HRMS (ESI-TOF) m/z Calcd for C15
H
15
2
N O 239.1184 [M +
+
H] ; Found 239.1190; Chiral HPLC: tR: 8.58 and 13.24 min, 1:1 mixture (column: Chiralpak AD-H, 250
-1
x 4.6 mm, 5 Pm, eluent: 20% EtOH in heptane, flow: 1 mL/min, temp: 25 °C); IR (νmax, cm ): 3289,
1
599; Anal. Calcd for C15
H
14
N
2
O: C, 75.61; H, 5.92; N, 11.76%. Found: C, 75.78; H, 6.13; N, 12.01%.
5
-(4-Methoxyphenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6b). General procedure A was
followed using 2-bromo-1-(4-methoxyphenyl)ethan-1-one. Purification by silica flash column
chromatography (35% EtOAc in n-heptane) followed basic preparative HPLC afforded compound 6b
1
(
200 mg, 40% yield) as an amorphous solid; H NMR (400 MHz, CDCl
3
) δ 7.71 – 7.64 (m, 2H), 7.48 –
7
1
1
2
.37 (m, 3H), 7.32 – 7.26 (m, 2H), 6.96 – 6.89 (m, 2H), 5.02 (s, 1H), 4.70 – 4.61 (m, 1H), 4.29 – 4.19 (m,
1
3
H), 3.81 (s, 3H), 3.70 (dd, J = 11.0, 7.6 Hz, 1H); C NMR (101 MHz, CDCl
3
) δ 160.0, 152.9, 132.9,
30.8, 130.4, 128.8, 128.2, 126.0, 114.6, 69.9, 55.5, 53.8; HRMS (ESI-TOF) m/z Calcd for C16
H
17
N
2
O
2
+
-1
69.1287 [M + H] ; Found 269.1290; IR (νmax, cm ): 3318, 1604; Anal. Calcd for C16
H
16
N
2
2
O : C, 71.62;
H, 6.01; N, 10.44%. Found: C, 71.67; H, 6.26; N, 10.56%.
5
-Methyl-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6d). General procedure A was followed using
-chloropropan-2-one. Purification by silica flash column chromatography (30% EtOAc in n-heptane)
1
followed by basic preparative HPLC afforded compound 6d (41 mg, 12% yield) as an amorphous solid;
1H NMR (400 MHz, CDCl
) δ 7.69 – 7.56 (m, 2H), 7.51 – 7.34 (m, 3H), 4.60 (s, 1H), 4.19 – 4.06 (m, 1H),
.85 – 3.65 (m, 1H), 3.50 (dd, J = 10.8, 7.1 Hz, 1H), 1.27 (d, J = 6.4 Hz, 3H); 13C NMR (101 MHz,
3
3
CDCl ) δ 152.5, 133.2 , 130.3, 128.8, 126.0, 69.4, 45.8, 18.6; HRMS (ESI-TOF) m/z Calcd for
3
+
-1
C
10
H
13
N
2
O 177.1028 [M + H] ; Found 177.1030; IR (νmax, cm ): 3232, 1603; Anal. Calcd for
C
10
H
12
N
2
O: C, 68.16; H, 6.86; N, 15.90%. Found: C, 67.87; H, 7.26; N, 16.11%.
5
-Cyclohexyl-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6e). General procedure A was followed
using 2-bromo-1-cyclohexylethan-1-one. Purification by trituration from EtOAc afforded compound 6e
1
(
(
233 mg, 51% yield) as a crystalline solid; mp 165 – 166 °C; H NMR (400 MHz, CDCl
3
) δ 7.66 – 7.60
m, 2H), 7.46 – 7.36 (m, 3H), 4.73 (s, 1H), 4.07 (dd, J = 11.0, 3.4 Hz, 1H), 3.81 (dd, J = 11.0, 6.0 Hz, 1H),
3
1
1
+
.38 – 3.30 (m, 1H), 1.91 (d, J = 12.2 Hz, 1H), 1.86 – 1.76 (m, 3H), 1.76 – 1.67 (m, 1H), 1.57 – 1.48 (m,
1
3
H), 1.35 – 1.16 (m, 3H), 1.16 – 1.01 (m, 2H); C NMR (101 MHz, CDCl
3
) δ 152.8, 133.3, 130.2, 128.7,
O 245.1654 [M
O: C, 73.74; H, 8.25; N,
26.0, 66.0, 55.0, 40.6, 29.1, 28.9, 26.4, 26.0; HRMS (ESI-TOF) m/z Calcd for C15
H
21
N
2
+
-1
H] ; Found 245.1654; IR (νmax, cm ): 3360, 1606; Anal. Calcd for C15
1.47%. Found: C, 73.70; H, 8.41; N, 11.09%.
-(tert-Butyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6f). General procedure A was followed
H
20
N
2
1
5
using 1-bromo-3,3-dimethylbutan-2-one. Purification by silica flash column chromatography (35%

2180
HETEROCYCLES, Vol. 92, No. 12, 2016
EtOAc in n-heptane) followed by basic preparative HPLC afforded compound 6f (178 mg, 43% yield) as
1
an amorphous solid; H NMR (400 MHz, CDCl
3
) δ 7.70 – 7.56 (m, 2H), 7.51 – 7.34 (m, 3H), 4.74 (s, 1H),
1
3
4
.17 – 4.03 (m, 1H), 3.83 (dd, J = 11.2, 6.6 Hz, 1H), 3.41 – 3.23 (m, 1H), 1.03 (s, 9H); C NMR (101
MHz, CDCl ) δ 153.4, 133.3, 130.3, 128.8, 126.0, 64.9, 58.6, 33.6, 26.0; HRMS (ESI-TOF) m/z Calcd for
3
+
-1
C
13
H
19
N
2
O 219.1498 [M + H] ; Found 219.1497; IR (νmax, cm ): 3204, 1606; Anal. Calcd for
C
13
H
18
N
2
O: C, 71.53; H, 8.31; N, 12.83%. Found: C, 71.21; H, 8.65; N, 12.78%.
N'-((2-Bromoallyl)oxy)benzimidamide (7). To a solution of N'-hydroxybenzimidamide 4 (2.28 g, 16.8
mmol) in dry DMF (15 mL) under nitrogen atmosphere at 0 °C, was added sodium hydride (60%
dispersion in mineral oil, 738 mg, 18.4 mmol). The resulting suspension was stirred at rt for 20 min,
2
,3-dibromoprop-1-ene (3.69 g, 18.4 mmol) was added and the mixture was stirred at rt for 20 h. The
reaction mixture was poured into water and was extracted with EtOAc twice. The combined organic
layers were washed with brine, dried using Na SO , concentrated and the crude product was purified by
2
4
silica flash column chromatography (10% to 60% EtOAc in n-heptane) to afford compound 7 (3.2 g, 75%
1
yield) as an oil; H NMR (400 MHz, CDCl
3
) δ 7.67 – 7.57 (m, 2H), 7.45 – 7.33 (m, 3H), 5.97 – 5.91 (m,
13
1
H), 5.66 – 5.60 (m, 1H), 4.89 (s, 2H), 4.72 – 4.65 (m, 2H); C NMR (101 MHz, CDCl
3
) δ 152.8, 132.2,
1
30.1, 129.7, 128.6, 126.0, 117.6, 77.0; HRMS (ESI-TOF) m/z Calcd for C10
H12BrN
2
O 255.0133 [M +
+
H] ; Found 255.0130.
N'-((2-Methylallyl)oxy)benzimidamide (8d). To a solution of N'-hydroxybenzimidamide 4 (500 mg,
.67 mmol) in dry DMF (15 mL) under nitrogen atmosphere, sodium hydride (60% dispersion in mineral
3
oil, 154 mg, 3.86 mmol) was added in portions and the resulting suspension was stirred at rt for 30 min.
Then, a solution of 3-bromo-2-methylpropene (992 mg, 7.34 mmol) in dry DMF (5 mL) was added and
the resulting mixture was stirred at rt for 1 h. The mixture was diluted with water and extracted with
EtOAc twice. The combined organic layers were washed with water, brine, dried using Na
2
SO ,
4
concentrated and purified by silica flash column chromatography (20% EtOAc in n-heptane) to afford
1
compound 8d (579 mg, 81% yield) as an oil; H NMR (400 MHz, CDCl
3
) δ 7.71 – 7.55 (m, 2H), 7.45 –
7.30 (m, 3H), 5.09 – 4.96 (m, 1H), 5.00 – 4.89 (m, 1H), 4.83 (s, 2H), 4.54 (s, 2H), 1.89 – 1.73 (m, 3H);
13C NMR (101 MHz, CDCl
) δ 152.0, 142.6, 132.7, 130.0, 128.7, 126.0, 112.2, 19.9; HRMS (ESI-TOF)
3
+
m/z Calcd for C11
H
15
N
2
O 191.1184 [M + H] ; Found 191.1180.
General procedure B for the synthesis of N'-((2-substituted allyl)oxy)benzimidamides via Suzuki
cross-coupling. Through a 0.2 M solution of 7, Na CO (3 equiv.) and the appropriate boronic acid (2.2
equiv.) in DME/water (2:1, v/v), nitrogen was bubbled for 10 min. Then,
,1'-bis(diphenylphosphino)ferrocenepalladium(II) dichloride (0.05 equiv.) was added and the mixture
was heated at the indicated temperature for the indicated time. The reaction was cooled to rt, partitioned
2
3
1

HETEROCYCLES, Vol. 92, No. 12, 2016
2181
between water and EtOAc, the organic layer was separated, dried using Na
2
SO
4
and concentrated to
afford the crude product that was purified as indicated.
N'-((2-Phenylallyl)oxy)benzimidamide (8a). General procedure B was followed starting from 7 (250 mg,
.98 mmol) using phenylboronic acid and stirring at 80 °C for 30 min. Purification by silica flash column
chromatography (5% to 35% EtOAc in n-heptane) afforded compound 8a (180 mg, 72% yield) as an oil;
1H NMR (400 MHz, CDCl
) δ 7.61 (dd, J = 7.5, 1.7 Hz, 2H), 7.51 (d, J = 7.3 Hz, 2H), 7.43 – 7.19 (m,
0
3
1
3
6
H), 5.57 (s, 1H), 5.41 (s, 1H), 5.01 (s, 2H), 4.74 (s, 2H); C NMR (101 MHz, CDCl ) δ 152.4, 144.3,
3
1
39.0, 132.6, 130.0, 128.7, 128.4, 127.8, 126.2, 126.0, 114.9, 75.6; HRMS (ESI-TOF) m/z Calcd for
+
C
16
H
17
N
2
O 253.1341 [M + H] ; Found 253.1341.
N'-((2-(4-Methoxyphenyl)allyl)oxy)benzimidamide (8b). General procedure B was followed starting
from 7 (250 mg, 0.98 mmol) using 4-methoxyphenylboronic acid and stirring at 80 °C for 30 min.
1
Purification by basic preparative HPLC afforded compound 8b (169 mg, 61% yield) as an oil; H NMR
(
400 MHz, CDCl
3
) δ 7.63 (d, J = 7.5 Hz, 2H), 7.47 (d, J = 8.5 Hz, 2H), 7.44 – 7.33 (m, 3H), 6.88 (d, J =
8
.5 Hz, 2H), 5.50 (s, 1H), 5.32 (s, 1H), 4.99 (s, 2H), 4.76 (s, 2H), 3.81 (s, 3H); 13C NMR (101 MHz,
CDCl
3
) δ 159.3, 152.2, 143.4, 132.5, 131.4, 129.9, 128.6, 127.3, 125.9, 113.7, 113.2, 75.7, 55.3; HRMS
+
(ESI-TOF) m/z Calcd for C17
H
19
N
2
O
2
283.1457 [M + H] ; Found 283.1446.
N'-((2-(4-Chlorophenyl)allyl)oxy)benzimidamide (8c). General procedure B was followed starting
from 7 (209 mg, 0.82 mmol) using 1.1 equiv. of 4-chlorophenylboronic acid and stirring at 70 °C for 30
min. Purification by silica flash column chromatography (5% to 30% EtOAc in n-heptane) afforded
1
compound 8c (148 mg, 63% yield) as a yellow oil; H NMR (400 MHz, CDCl
3
) δ 7.61 (d, J = 7.7 Hz,
2H), 7.49 – 7.34 (m, 5H), 7.31 (d, J = 8.2 Hz, 2H), 5.56 (s, 1H), 5.43 (s, 1H), 4.98 (s, 2H), 4.74 (s, 2H);
13C NMR (101 MHz, CDCl
) δ 152.4, 143.3, 137.4, 133.6, 132.5, 130.1, 128.8, 128.6, 127.6, 126.1, 115.6,
3
+
7
5.5; HRMS (ESI-TOF) m/z Calcd for C16
H16ClN
2
O 287.0958 [M + H] ; Found 287.0951.
N'-((2-(4-Methylphenyl)allyl)oxy)benzimidamide (8i). General procedure B was followed starting from
7
(150 mg, 0.59 mmol) using 4-methylphenylboronic acid and stirring at 80 °C for 1 h. Purification by
1
basic preparative HPLC afforded compound 8i (94 mg, 60% yield) as an oil. H NMR (400 MHz, CDCl
3
)
δ 7.61 (dd, J = 7.7, 1.8 Hz, 2H), 7.48 – 7.31 (m, 5H), 7.14 (d, J = 8.0 Hz, 2H), 5.54 (s, 1H), 5.36 (s, 1H),
1
3
4
.99 (s, 2H), 2.34 (s, 3H); C NMR (101 MHz, CDCl
3
) δ 152.3, 144.0, 137. 6, 136.0, 132.6, 130.0, 129.1,
O 267.1497 [M + H]+;
1
28.7, 126.1, 126.0, 114.0, 75.6, 21.2; HRMS (ESI-TOF) m/z Calcd for C17
H
19
N
2
Found 267.1500.
N'-((2-(4-Fluorophenyl)allyl)oxy)benzimidamide (8j). General procedure B was followed starting from
7
(150 mg, 0.59 mmol) using 4-fluorophenylboronic acid and stirring at 80 °C for 1 h. Purification by
1
basic preparative HPLC afforded compound 8j (97 mg, 61% yield) as an oil; H NMR (400 MHz, CDCl
3
)
δ 7.60 (dd, J = 7.7, 1.7 Hz, 2H), 7.53 – 7.44 (m, 2H), 7.43 – 7.31 (m, 3H), 7.06 – 6.97 (m, 2H), 5.50 (s,

2182
HETEROCYCLES, Vol. 92, No. 12, 2016
1
1
7
H), 5.38 (s, 1H), 4.75 (s, 2H); 13C NMR (101 MHz, CDCl
3
) δ 162.5 (d, J = 246.6 Hz), 152.4, 143.4,
35.0 (d, J = 3.2 Hz), 132.5, 130.1, 128.7, 127.9 (d, J = 8.0 Hz), 126.0, 115.3 (d, J = 21.3 Hz), 114.9,
+
5.6; HRMS (ESI-TOF) m/z Calcd for C16
2
H16FN O 271.1247 [M + H] ; Found 271.1245.
N'-((2-(3-Methoxyphenyl)allyl)oxy)benzimidamide (8k). General procedure B was followed starting
from 7 (150 mg, 0.59 mmol) using 3-methoxyphenylboronic acid and stirring at 80 °C for 1 h.
1
Purification by basic preparative HPLC afforded compound 8k (103 mg, 62% yield) as an oil; H NMR
(
400 MHz, CDCl
3
) δ 7.56 – 7.44 (m, 2H), 7.33 – 7.22 (m, 3H), 7.16 (t, J = 8.0 Hz, 1H), 7.05 – 6.99 (m,
1
3
1
H), 6.99 – 6.94 (m, 1H), 6.74 (dd, 1H), 5.47 (s, 1H), 5.32 (d, J = 1.2 Hz, 1H), 4.90 (s, 2H), 4.68 (s, 2H),
1
3
.69 (s, 3H); C NMR (101 MHz, CDCl
3
) δ 159.6, 152.3, 144.2, 140.5, 132.5, 129.9, 129.3, 128.6, 126.0,
283.1447 [M + H]+;
18.7, 115.1, 113.2, 112.0, 75.5, 55.3; HRMS (ESI-TOF) m/z Calcd for C17
H
19
N
2
O
2
Found 283.1450.
N'-((2-(3-Chlorophenyl)allyl)oxy)benzimidamide (8l). General procedure B was followed starting from
7
(150 mg, 0.59 mmol) using 1.1 equiv. of 3-chlorophenylboronic acid and stirring at 70 °C for 1 h.
1
Purification by basic preparative HPLC afforded compound 8l (93 mg, 55% yield) as an oil; H NMR
(
400 MHz, CDCl ) δ 7.67 – 7.55 (m, 3H), 7.51 (s, 1H), 7.45 – 7.32 (m, 6H), 7.29 – 7.21 (m, 4H), 5.57 (s,
3
1
3
1
H), 5.45 (d, 2H), 4.97 (s, 3H), 4.75 (s, 2H); C NMR (101 MHz, CDCl ) δ 152.4, 143.4, 140.9, 134.4,
3
1
32.5, 130.1, 129.7, 128.7, 127.8, 126.5, 126.1, 124.5, 116.2, 75.4; HRMS (ESI-TOF) m/z Calcd for
+
C
16
H16ClN
2
O 287.0951 [M + H] ; Found 287.0950.
N'-((2-(Benzofuran-3-yl)allyl)oxy)benzimidamide (8m). General procedure B was followed starting
from 7 (250 mg, 0.98 mmol) using benzofuran-3-boronic acid and stirring at 80 °C for 2 h. Purification
by silica flash column chromatography (20% EtOAc in n-heptane) afforded compound 8m (270 mg, 66%
1
yield) as a yellow oil; H NMR (400 MHz, CDCl
3
) δ 7.86 – 7.80 (m, 2H), 7.63 – 7.59 (m, 2H), 7.49 (dd, J
=
7.1, 1.8 Hz, 1H), 7.41 – 7.33 (m, 3H), 7.33 – 7.25 (m, 2H), 5.79 (s, 1H), 5.56 – 5.51 (m, 1H), 4.95 (s,
2
1
2
H), 4.81 (s, 2H); 13C NMR (101 MHz, CDCl ) δ 155.6, 152.3, 142. 9, 136.4, 132.5, 130.1, 128.7, 126.2,
3
26.0, 124.5, 123.1, 121.2, 119.6, 115.1, 111.7, 76.5; HRMS (ESI-TOF) m/z Calcd for C18
H
17
N O
2 2
+
93.1290 [M + H] ; Found 293.1289.
N'-((2-(1-Methyl-1H-indol-2-yl)allyl)oxy)benzimidamide (8n). General procedure B was followed
starting from 7 (250 mg, 0.98 mmol) using 1-methyl-2-indoleboronic acid pinacol ester and stirring at
8
0 °C for 90 min. Purification by silica flash column chromatography (20% EtOAc in n-heptane) afforded
1
compound 8n (296 mg, 97% yield) as an oil; H NMR (400 MHz, CDCl
3
) δ 7.67 – 7.53 (m, 3H), 7.45 –
7
.33 (m, 3H), 7.34 – 7.28 (m, 1H), 7.27 – 7.18 (m, 1H), 7.14 – 7.07 (m, 1H), 6.55 (s, 1H), 5.70 (d, J = 1.3
Hz, 1H), 5.38 (s, 1H), 4.94 (s, 2H), 4.74 (s, 2H), 3.77 (s, 3H); 13C NMR (101 MHz, CDCl
) δ 152.5,
39.1, 138.5, 137.5, 132.6, 130.1, 128.7, 126.0, 121.9, 120.7, 119.8, 117.9, 109.6, 101.4, 76.2, 31.3;
3
1
+
HRMS (ESI-TOF) m/z Calcd for C19
H
20
N O 306.1606 [M + H] ; Found 306.1611.
3

HETEROCYCLES, Vol. 92, No. 12, 2016
2183
N'-((2-(Pyridin-3-yl)allyl)oxy)benzimidamide (8o). General procedure B was followed starting from 7
200 mg, 0.78 mmol) using pyridine-3-boronic acid and stirring at 80 °C for 3 h. Purification by silica
(
flash column chromatography (45% EtOAc in n-heptane) afforded compound 8o (126 mg, 62% yield) as
1
a yellow oil; H NMR (400 MHz, CDCl
3
) δ 8.78 (s, 1H), 8.52 (d, J = 3.9 Hz, 1H), 7.81 (d, J = 8.0 Hz,
1
5
1
H), 7.60 (dd, J = 7.6, 1.5 Hz, 2H), 7.47 – 7.33 (m, 3H), 7.31 – 7.22 (m, 1H), 5.62 (s, 1H), 5.51 (s, 1H),
1
3
.00 (s, 2H), 4.77 (s, 2H); C NMR (101 MHz, CDCl
16.8, 75.3; HRMS (ESI-TOF) m/z Calcd for C15
3
) δ 148.9, 141.9, 133.6, 132.5, 130.1, 128.7, 126.1,
+
H
16
N
3
O 254.1293 [M + H] ; Found 254.1290.
General procedure C for the synthesis of 5-substituted 3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazines via
oxidative cleavage and reductive amination. To a 0.15 M solution of the appropriate
N'-allyloxy-benzimidamide in THF/water (3:1, v/v), osmium tetroxide (4 wt% in water, 0.05 equiv.) and
sodium periodate (3.5 equiv.) were added. The mixture was stirred at rt for 1 h (unless indicated
otherwise), diluted with water and extracted with DCM twice. The combined organic layers were washed
with brine, dried using Na
2
SO and concentrated to afford the crude intermediate. A 0.15 M solution of
4
crude intermediate in MeOH/acetic acid (3:1, v/v) was heated to 60 °C for 1 h and sodium
cyanoborohydride (1.1 equiv.) was added. The mixture was stirred at 60 °C for 3 h, poured into a 1M
sodium hydroxide solution and extracted with EtOAc twice. The combined organic layers were washed
with brine, dried using Na
described.
2
SO and concentrated to afford the crude product which was purified as
4
3
,5-Diphenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6a). General procedure C was followed using
N'-((2-phenylallyl)oxy)benzimidamide 8a (150 mg, 0.55 mmol). Purification by silica flash column
chromatography (30% EtOAc in n-heptane) afforded compound 6a (104 mg, 80% yield) as a solid.
5-(4-Chlorophenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6b). General procedure C was
followed using N'-((2-(4-methoxyphenyl)allyl)oxy)benzimidamide 8b (137 mg, 0.49 mmol). Purification
by silica flash column chromatography (35% EtOAc in n-heptane) afforded compound 6b (77 mg, 59%
yield) as a solid.
5-(4-Chlorophenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6c). General procedure C was
followed using N'-((2-(4-chlorophenyl)allyl)oxy)benzimidamide 8c (117 mg, 0.41 mmol). The oxidative
cleavage was stirred for 2 h. Purification by silica flash column chromatography (30% EtOAc in
1
n-heptane) afforded compound 6c (75 mg, 66% yield) as a solid; H NMR (400 MHz, CDCl
3
) δ 7.74 –
7
1
1
.61 (m, 2H), 7.50 – 7.35 (m, 5H), 7.35 – 7.28 (m, 2H), 5.07 (s, 1H), 4.82 – 4.61 (m, 2H), 4.30 – 4.17 (m,
1
3
H), 3.77 (dd, J = 11.1, 6.7 Hz, 1H); C NMR (101 MHz, CDCl
29.2, 128.8, 128.3, 126.0, 69.4, 53.5; HRMS (ESI-TOF) m/z Calcd for C15
3
) δ 152.9, 137.9, 134.3, 132.6, 130.5,
O 273.0793 [M +
O: C, 66.06; H, 4.80; N,
H
14ClN
2
+
-1
H] ; Found 273.0795; IR (νmax, cm ): 3297, 1601; Anal. Calcd for C15
0.27%. Found: C, 65.73; H, 4.51; N, 10.24%.
H13ClN
2
1

2184
HETEROCYCLES, Vol. 92, No. 12, 2016
5
-Methyl-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6d). General procedure C was followed using
N'-((2-methylallyl)oxy)benzimidamide 8d (575 mg, 3.0 mmol). Purification by silica flash column
chromatography (35% EtOAc in n-heptane) afforded compound 6d (311 mg, 57% yield) as a solid.
5
-(4-Methylphenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6i). General procedure C was
followed using N'-((2-(4-methylphenyl)allyl)oxy)benzimidamide 8i (71 mg, 0.27 mmol). Purification by
silica flash column chromatography (0% to 60% EtOAc in n-heptane) followed by lyophilization afforded
1
compound 6i (46 mg, 68% yield) as an amorphous solid; H NMR (400 MHz, CDCl
3
) δ 7.70 – 7.65 (m,
2
1
H), 7.48 – 7.36 (m, 3H), 7.24 (d, J = 8.5 Hz, 2H), 7.20 (d, J = 8.5 Hz, 2H), 5.08 (s, 1H), 4.69 – 4.62 (m,
1
3
H), 4.22 (dd, J = 11.0, 4.0 Hz, 1H), 3.69 (dd, J = 11.0, 7.5 Hz, 1H), 2.36 (s, 3H); C NMR (101 MHz,
CDCl
3
) δ 152.9, 138.6, 135.8, 132.9, 130.4, 129.8, 128.8, 126.9, 126.0, 69.8, 54.0, 21.2; HRMS
+
-1
(ESI-TOF) m/z Calcd for C16
H
17
N
2
O 253.1341 [M + H] ; Found 253.1337; IR (νmax, cm ): 3332, 1606.
5-(4-Fluorophenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6j). General procedure C was
followed using N'-((2-(4-fluorophenyl)allyl)oxy)benzimidamide 8j (85 mg, 0.31 mmol). Purification by
silica flash column chromatography (0% to 60% EtOAc in n-heptane) followed by lyophilization afforded
1
compound 6j (57 mg, 71% yield) as an amorphous solid; H NMR (400 MHz, CDCl
3
) δ 7.70 – 7.60 (m,
2H), 7.48 – 7.35 (m, 3H), 7.35 – 7.28 (m, 2H), 7.12 – 7.02 (m, 2H), 5.29 (s, 1H), 4.72 – 4.61 (m, 1H),
1
3
4
.15 (dd, J = 11.1, 3.8 Hz, 1H), 3.70 (dd, J = 11.1, 6.6 Hz, 1H); C NMR (101 MHz, CDCl ) δ 162.8 (d,
3
J = 247.2 Hz), 152.9, 135.1 (d, J = 3.1 Hz), 132.7, 130.4, 128.8, 128.6 (d, J = 8.2 Hz), 126.0, 116.0 (d, J
+
=
21.7 Hz), 69.5, 53.5; HRMS (ESI-TOF) m/z Calcd for C15
H14FN
2
O 257.1090 [M + H] ; Found
-
1
2
57.1088; IR (νmax, cm ): 3344, 1602; Anal. Calcd for C15
Found: C, 70.06; H, 5.03; N, 10.90%.
-(3-Methoxyphenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6k). General procedure C was
H
13FN
2
O: C, 70.30; H, 5.11; N, 10.93%.
5
followed using N'-((2-(3-methoxyphenyl)allyl)oxy)benzimidamide 8k (83 mg, 0.29 mmol). Purification
by silica flash column chromatography (0% to 60% EtOAc in n-heptane) followed by lyophilization
1
afforded compound 6k (59 mg, 75% yield) as an amorphous solid; H NMR (400 MHz, CDCl
3
) δ 7.77 –
7
5
1
1
2
5
.61 (m, 2H), 7.52 – 7.36 (m, 3H), 7.37 – 7.28 (m, 1H), 6.95 (d, J = 7.7 Hz, 1H), 6.92 – 6.85 (m, 2H),
.10 (s, 1H), 4.73 – 4.60 (m, 1H), 4.25 (dd, J = 11.0, 4.0 Hz, 1H), 3.81 (s, 3H), 3.74 (dd, J = 11.0, 7.3 Hz,
1
3
H); C NMR (101 MHz, CDCl
3
) δ 160.3, 152.8, 140.5, 132.9, 130.4, 130.3, 128.8, 126.0, 119.1, 113.8,
+
12.8, 69.7, 55.4, 54.2; HRMS (ESI-TOF) m/z Calcd for C16
69.1288.
H
17
N
2
O
2
269.1290 [M + H] ; Found
-(3-Chlorophenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6l). General procedure C was
followed using N'-((2-(3-chlorophenyl)allyl)oxy)benzimidamide 8l (83 mg, 0.29 mmol). Purification by
silica flash column chromatography (0% to 60% EtOAc in n-heptane) followed by lyophilization afforded
1
compound 6l (52 mg, 66% yield) as an amorphous solid; H NMR (400 MHz, CDCl
3
) δ 7.70 – 7.59 (m,

HETEROCYCLES, Vol. 92, No. 12, 2016
2185
2
4
1
H), 7.48 – 7.36 (m, 3H), 7.35 – 7.29 (m, 3H), 7.25 – 7.19 (m, 1H), 5.33 (s, 1H), 4.70 – 4.61 (m, 1H),
1
3
.14 (dd, J = 11.1, 3.8 Hz, 1H), 3.73 (dd, J = 11.1, 6.3 Hz, 1H); C NMR (101 MHz, CDCl ) δ 152.9,
3
41.5, 135.0, 132.6, 130.5, 130.4, 128.8, 128.7, 127.1, 126.0, 125.1, 69.3, 53.7; HRMS (ESI-TOF) m/z
+
Calcd for C15
H14ClN
2
O 273.0795 [M + H] ; Found 273.0791.
5-(Benzofuran-3-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6m). General procedure C was
followed using N'-((2-(benzofuran-3-yl)allyl)oxy)benzimidamide (8m) (190 mg, 0.65 mmol). Purification
by silica flash column chromatography (30% EtOAc in n-heptane) afforded compound 6m (67 mg, 38%
1
yield) as an oil; H NMR (400 MHz, CDCl
3
) δ 7.63 – 7.54 (m, 4H), 7.49 (d, J = 8.3 Hz, 1H), 7.44 – 7.37
(m, 1H), 7.36 – 7.28 (m, 3H), 7.26 – 7.20 (m, 1H), 5.44 (s, 1H), 4.95 – 4.86 (m, 1H), 4.19 (dd, J = 11.1,
1
3
4
.0 Hz, 1H), 3.98 (dd, J = 11.1, 6.7 Hz, 1H); C NMR (101 MHz, CDCl ) δ 155.8, 152.9, 142.8, 132.6,
3
1
30.4, 128.7, 126.0, 125.6, 125.0, 123.1, 119.9, 119.0, 112.0, 67.5, 46.6; HRMS (ESI-TOF) m/z Calcd for
+
C
17
H
15
N
2
O
2
279.1134 [M + H] ; Found 279.1132.
5-(Pyridin-3-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6o). General procedure C was followed
using N'-((2-(pyridin-3-yl)allyl)oxy)benzimidamide (8o) (310 mg, 1.22 mmol). The oxidative cleavage
was stirred for 16 h. Purification by silica flash column chromatography (5% MeOH in DCM) afforded
1
compound 6o (66 mg, 22% yield) as an off white solid; H NMR (400 MHz, CDCl
3
) δ 8.53 – 8.42 (m,
2H), 7.68 – 7.58 (m, 3H), 7.47 – 7.39 (m, 1H), 7.39 – 7.31 (m, 2H), 7.27 (dd, J = 7.9, 4.8 Hz, 1H), 5.96 (d,
1
3
J = 2.2 Hz, 1H), 4.74 – 4.62 (m, 1H), 4.08 (dd, J = 11.1, 3.7 Hz, 1H), 3.78 (dd, J = 11.1, 5.3 Hz, 1H); C
3
NMR (101 MHz, CDCl ) δ 153.2, 149.6, 148.3, 135.7, 134.7, 132.5, 130.5, 128.7, 126.0, 123.9, 68.8,
+
5
1.8; HRMS (ESI-TOF) m/z Calcd for C14
H
14
N
3
O 240.1137 [M + H] ; Found 240.1138.
General procedure D for the alkylation of (N-substituted) N'-hydroxybenzimidamides. To a solution of the
appropriate N'-hydroxybenzimidamide and 1-bromo-2,2-diethoxyethane (1.1 equiv.) in DMSO was added
KOH (1.2 equiv.) and the mixture was stirred at room temperature for 20 h. The reaction mixture was
diluted with water, extracted with EtOAc, the combined organic extracts were washed twice with 0.1 M
aqueous sodium hydroxide solution and once with brine. The organic layer was dried over Na
2
SO ,
4
concentrated and the crude product was purified by silica flash column chromatography using the
indicated gradient.
N'-(2,2-Diethoxyethoxy)benzimidamide (9). General procedure
D
was followed using
N'-hydroxybenzimidamide 4 (10.0 g, 73.7 mmol) in 100 mL of DMSO. Purification by silica flash
column chromatography (15% to 30% EtOAc in n-heptane) afforded compound 9 (14.3 g, 77% yield) as
1
an oil; H NMR (400 MHz, CDCl
3
) δ 7.70 – 7.57 (m, 2H), 7.47 – 7.33 (m, 3H), 4.86 (t, J = 5.3 Hz, 3H),
4
6
.11 (d, J = 5.4 Hz, 2H), 3.76 (dq, J = 9.5, 7.1 Hz, 2H), 3.61 (dq, J = 9.4, 7.0 Hz, 2H), 1.24 (t, J = 7.1 Hz,
1
3
H); C NMR (101 MHz, CDCl
3
) δ 152.5, 132.6, 130.1, 128.7, 126.0, 100.5, 73.6, 62.6, 15.5; HRMS
+
(ESI-TOF) m/z Calcd for C13
H
20
N
2
O
3
Na 275.1372 [M + Na] ; Found 275.1374.

2186
HETEROCYCLES, Vol. 92, No. 12, 2016
5
-Ethoxy-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine
(10).
To
a
solution
of
N'-(2,2-diethoxyethoxy)benzimidamide 9 (5.0 g, 19.8 mmol) in EtOH (200 mL), H
2
SO (1.94 g, 19.8
4
mmol) in water (10 mL) was added and the mixture was stirred at 65 °C for 1 week. The reaction mixture
was quenched using solid sodium bicarbonate. When gas evolution had ceased, the reaction mixture was
concentrated to approximately 50 mL volume and partitioned between water and EtOAc. The layers were
separated and the aqueous layer was extracted with EtOAc twice. The combined organic layes were
washed with water, brine, dried over Na
2
SO , concentrated and the crude product was purified by column
4
chromatography (45% to 65% EtOAc in n-heptane) to afford compound 10 (2.8 g, 69% yield) as a solid;
1
mp 112 – 113 °C; H NMR (400 MHz, DMSO-d
6
) δ 8.02 (d, J = 5.0 Hz, 1H), 7.71 – 7.59 (m, 2H), 7.51 –
7.37 (m, 3H), 4.86 – 4.78 (m, 1H), 4.07 – 3.98 (m, 1H), 3.76 – 3.64 (m, 1H), 3.54 – 3.38 (m, 2H), 1.15 (t,
13
J = 7.0 Hz, 3H); C NMR (101 MHz, DMSO-d
5.1; HRMS (ESI-TOF) m/z Calcd for C11
6
) δ 151.2, 132.5, 129.9, 128.3, 125.9, 77.2, 65.9, 61.2,
+
1
H
15
N
2
O
2
207.1134 [M + H] ; Found 207.1139.
N'-(2,2-Diethoxyethoxy)-N-methylbenzimidamide (13a). General procedure D was followed using
N'-hydroxy-N-methylbenzimidamide 12a (488 mg, 3.25 mmol) in 5 mL of DMSO. Purification by silica
flash column chromatography (0% to 30% EtOAc in n-heptane) afforded compound 13a (444 mg, 51%
1
yield) as a pale yellow oil; H NMR (400 MHz, CDCl
3
) δ 7.61 – 7.30 (m, 5H), 5.47 – 5.12 (m, 1H), 4.06
(d, J = 5.4 Hz, 2H), 3.75 (dq, J = 9.4, 7.1 Hz, 2H), 3.60 (dq, J = 9.5, 7.1 Hz, 2H), 2.71 (d, J = 5.3 Hz, 3H),
13
1
.24 (t, J = 7.1 Hz, 6H); C NMR (101 MHz, CDCl
2.6, 30.8, 15.6; HRMS (ESI-TOF) m/z Calcd for C14
3
) δ 157.6, 131.2, 129.7, 128.8, 128.6, 100.5, 73.3,
+
6
H
22
N
2
NaO
3
289.1528 [M + Na] ; Found 289.1529.
N'-(2,2-Diethoxyethoxy)-N-phenylbenzimidamide (13b). General procedure D was followed using
N'-hydroxy-N-phenylbenzimidamide 12b (577 mg, 2.72 mmol) in 5 mL of DMSO. Purification by silica
flash column chromatography (8% to 30% EtOAc in n-heptane) afforded compound 13b (392 mg, 44%
1
yield) as an oil; H NMR (400 MHz, CDCl
3
) δ 7.46 – 7.39 (m, 2H), 7.39 – 7.21 (m, 4H), 7.14 – 7.04 (m,
2
3
1
H), 6.95 – 6.87 (m, 1H), 6.68 – 6.60 (m, 2H), 4.89 (t, J = 5.4 Hz, 1H), 4.17 (d, J = 5.4 Hz, 2H), 3.83 –
1
3
.71 (m, 2H), 3.68 – 3.56 (m, 2H), 1.25 (t, J = 7.0 Hz, 6H); C NMR (101 MHz, CDCl ) δ 152.0, 139.9,
3
31.2, 129.8, 128.9, 128.6, 128.5, 122.8, 121.4, 100.4, 73.7, 62.7, 15.6; HRMS (ESI-TOF) m/z Calcd for
+
C
19
H
24
N
2
NaO
3
351.1684 [M + Na] ; Found 351.1705.
General procedure E for the synthesis of 5-substituted 3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazines via
iminium ion additions. A 0.25 M solution of N'-(2,2-diethoxyethoxy)benzimidamide (9) in formic acid
was heated to 100 °C for 15 min and then cooled to rt. Next, 5 equivalents of nucleophile were added and
the mixture was stirred at the indicated temperature for the indicated time. The mixture was concentrated,
co-evaporated with DCM twice and the product was purified as indicated.
5-(Furan-2-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6p). General procedure E was followed
starting from 9 (1.14 g, 4.52 mmol) using furan as the nucleophile and stirring at rt for 20 h. Purification

HETEROCYCLES, Vol. 92, No. 12, 2016
2187
by silica flash column chromatography (20% to 40% EtOAc in n-heptane) afforded compound 6p (0.91 g,
1
8
7
1
1
2
8% yield) as a solid; mp 115 – 116 °C; H NMR (400 MHz, DMSO-d
6
) δ 7.76 – 7.59 (m, 4H), 7.49 –
.36 (m, 3H), 6.44 (dd, J = 3.2, 1.8 Hz, 1H), 6.40 – 6.32 (m, 1H), 4.77 (q, J = 3.7 Hz, 1H), 4.01 (dd, J =
1
3
1.0, 4.1 Hz, 1H), 3.91 (dd, J = 11.0, 3.5 Hz, 1H); C NMR (101 MHz, DMSO-d
6
) δ 153.6, 151.8, 142.3,
32.7, 129.8, 128.2, 126.0, 110.5, 106.9, 65.8, 47.2; HRMS (ESI-TOF) m/z Calcd for C13
H
13
N
2
O
2
+
-1
29.0977 [M + H] ; Found 229.0985; IR (νmax, cm ): 3377, 1605; Anal. Calcd for C13
H
12
N
2
2
O : C, 68.21;
H, 5.10; N, 12.07%. Found: C, 67.97; H, 4.82; N, 11.88%. Compound 6p was also synthesised from 10
by stirring with furan for 20 h at rt in 92% yield.
5-(1H-Indol-3-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6q). General procedure E was followed
starting from 9 (106 mg, 0.42 mmol) using indole as the nucleophile (2 equiv. added directly, an
additional 2 equiv. after 30 min, followed by an additional 1 equiv. after 1 h) and stirring at rt for 20 h.
Purification by silica flash column chromatography (15% to 50% EtOAc in n-heptane) followed by basic
1
preparative HPLC afforded compound 6q (82 mg, 70% yield) as an amorphous solid; H NMR (400 MHz,
DMSO-d
6
) δ 11.07 (s, 1H), 7.76 – 7.67 (m, 2H), 7.62 (d, J = 7.9 Hz, 1H), 7.51 (d, J = 1.9 Hz, 1H), 7.48 –
7.32 (m, 5H), 7.14 – 7.05 (m, 1H), 7.04 – 6.95 (m, 1H), 5.02 – 4.93 (m, 1H), 4.11 (dd, J = 10.8, 4.0 Hz,
1
3
1
H), 3.85 (dd, J = 10.8, 6.6 Hz, 1H); C NMR (101 MHz, DMSO-d
6
) δ 152.4, 136.5, 133.1, 129.6, 128.2,
1
26.1, 125.5, 123.6, 121.2, 118.8, 118.7, 113.4, 111.7, 68.1, 47.0; HRMS (ESI-TOF) m/z Calcd for
+
-1
C
C
17
H
16
N
3
O 278.1293 [M + H] ; Found 278.1294; IR (νmax, cm ): 3310, 1607; Anal. Calcd for
17
H
15
N
3
O: C, 73.63; H, 5.45; N, 15.15%. Found: C, 73.36; H, 5.44; N, 15.14%.
5-(1-Methyl-1H-indol-3-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6r). General procedure E was
followed starting from 9 (109 mg, 0.43 mmol) using 1-methylindole as the nucleophile (3 equiv. added
directly, an additional 2 equiv. after 1 h) and stirring at rt for 20 h. Purification by acidic preparative
1
HPLC afforded compound 6r (108 mg, 86% yield) as a yellow amorphous solid; H NMR (400 MHz,
DMSO-d
6
) δ 7.76 – 7.68 (m, 2H), 7.68 – 7.61 (m, 1H), 7.52 (d, J = 2.2 Hz, 1H), 7.49 – 7.37 (m, 4H), 7.35
(s, 1H), 7.21 – 7.12 (m, 1H), 7.08 – 7.00 (m, 1H), 5.01 – 4.93 (m, 1H), 4.09 (dd, J = 10.8, 3.9 Hz, 1H),
3
.85 (dd, J = 10.8, 6.2 Hz, 1H), 3.77 (s, 3H); 13C NMR (101 MHz, DMSO-d
29.7, 128.2, 127.8, 126.1, 125.9, 121.3, 119.0, 118.8, 112.8, 109.9, 68.1, 46.7, 32.4; HRMS (ESI-TOF)
6
) δ 152.3, 136.8, 133.1,
1
+
-1
m/z Calcd for C18
H
18
N O 292.1449 [M + H] ; Found 292.1448; IR (νmax, cm ): 3180, 1606; Anal. Calcd
3
for C18
H
17
N
3
O: C, 74.20; H, 5.88; N, 14.42%. Found: C, 73.84; H, 6.10; N, 14.61%.
5-(1H-Indazol-3-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6s). General procedure E was
followed starting from 9 (110 mg, 0.44 mmol) using indazole as the nucleophile and stirring at rt for 84 h.
Purification by silica flash column chromatography (20% to 50% EtOAc in n-heptane) afforded
1
compound 6s (106 mg, 87% yield) as a solid; mp 172 – 174 °C; H NMR (400 MHz, DMSO-d
6
) δ 8.50 (d,
J = 4.7 Hz, 1H), 8.15 (d, J = 0.9 Hz, 1H), 7.83 – 7.69 (m, 3H), 7.63 (dd, J = 8.6, 0.8 Hz, 1H), 7.54 – 7.42

2188
HETEROCYCLES, Vol. 92, No. 12, 2016
(m, 3H), 7.40 – 7.32 (m, 1H), 7.20 – 7.11 (m, 1H), 6.43 – 6.35 (m, 1H), 4.24 (dd, J = 11.7, 2.7 Hz, 1H),
4
1
2
.03 (dd, J = 11.7, 3.1 Hz, 1H); 13C NMR (101 MHz, DMSO-d
28.5, 126.2, 126.0, 124.4, 120.9, 120.8, 110.8, 66.5, 65.0; HRMS (ESI-TOF) m/z Calcd for C16
6
) δ 152.7, 138.5, 133.4, 131.9, 130.3,
H
15
4
N O
+
-1
79.1246 [M + H] ; Found 279.1248; IR (νmax, cm ): 3191, 1611; Anal. Calcd for C16
H
14
4
N O: C, 69.05;
H, 5.07; N, 20.13%. Found: C, 68.88; H, 4.86; N, 20.07%.
-(Benzofuran-2-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6t). General procedure E was
5
followed starting from 9 (111 mg, 0.44 mmol) using benzofuran as the nucleophile and stirring at 100 °C
for 2.5 h. Purification by SCX chromatography, basic preparative HPLC, followed by acidic preparative
1
HPLC afforded compound 6t (65 mg, 53% yield) as an amorphous solid; H NMR (400 MHz, DMSO-d
6
)
δ 7.88 (d, J = 4.2 Hz, 1H), 7.76 – 7.66 (m, 2H), 7.66 – 7.59 (m, 1H), 7.59 – 7.53 (m, 1H), 7.52 – 7.40 (m,
3
H), 7.33 – 7.19 (m, 2H), 6.87 – 6.81 (m, 1H), 4.96 (q, J = 3.5 Hz, 1H), 4.22 (dd, J = 11.1, 3.4 Hz, 1H),
.98 (dd, J = 11.1, 3.4 Hz, 1H); 13C NMR (101 MHz, DMSO-d
) δ 156.8, 154.2, 151.8, 132.7, 129.9,
28.3, 128.0, 126.0, 124.1, 122.9, 121.0, 111.1, 103.9, 65.3, 47.6; HRMS (ESI-TOF) m/z Calcd for
3
6
1
+
-1
C
C
17
H
15
N
2
O
2
279.1133 [M + H] ; Found 279.1130; IR (νmax, cm ): 3323, 1603; Anal. Calcd for
17
H
14
N
2
O
2
: C, 73.37; H, 5.07; N, 10.07%. Found: C, 72.82; H, 4.90; N,9.97 %.
5
-(Benzo[b]thiophen-2-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6u). General procedure E was
followed starting from 9 (0.51 g, 2.0 mmol) using benzo[b]thiophene as the nucleophile and stirring at
00 °C for 4 h. Purification by silica flash column chromatography (25% acetone in n-heptane) afforded a
1
mixture of isomers. Further purification by silica flash column chromatography (18% to 40% EtOAc in
1
n-heptane) afforded 6u (408 mg, 69%) as a solid; mp 87 – 89 °C; H NMR (400 MHz, DMSO-d
6
) δ 8.06
–
7
1
1
8.01 (m, 1H), 8.01 – 7.95 (m, 1H), 7.78 (d, J = 3.4 Hz, 1H), 7.77 – 7.70 (m, 2H), 7.66 – 7.61 (m, 1H),
.51 – 7.37 (m, 5H), 5.19 (q, J = 3.7 Hz, 1H), 4.08 (dd, J = 11.0, 3.6 Hz, 1H), 3.96 (dd, J = 11.0, 4.6 Hz,
H); 13C NMR (101 MHz, DMSO-d
) δ 152.3, 140.2, 136.9, 135.5, 132.9, 129.8, 128.3, 126.1, 124.6,
24.5, 124.3, 123.1, 121.9, 66.9, 48.2, HRMS (ESI-TOF) m/z Calcd for C17
OS 295.0905 [M + H]+;
OS: C, 69.36; H, 4.79; N, 9.52%.
6
H
15
N
2
-1
Found 295.0906; IR (νmax, cm ): 3310, 1605; Anal. Calcd for C17
H
14
N
2
Found: C, 69.22; H, 4.53; N, 9.22%.
5-(Benzo[d][1,3]dioxol-5-yl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6v). General procedure E
was followed starting from 9 (110 mg, 0.44 mmol) using 1,3-benzodioxole as the nucleophile and stirring
at 100 °C for 4.5 h. Purification by silica flash column chromatography (40% to 65% EtOAc in
1
n-heptane) afforded compound 6v (91 mg, 74% yield) as a solid; mp 155.5 – 156.5 °C; H NMR (400
MHz, DMSO-d
6
) δ 7.75 – 7.66 (m, 2H), 7.62 (d, J = 2.9 Hz, 1H), 7.50 – 7.38 (m, 3H), 6.97 – 6.88 (m,
H), 6.85 (dd, J = 8.1, 1.5 Hz, 1H), 6.00 (s, 2H), 4.63 (q, J = 3.6 Hz, 1H), 3.95 (dd, J = 10.9, 3.6 Hz, 1H),
.70 (dd, J = 10.9, 5.0 Hz, 1H); 13C NMR (101 MHz, DMSO-d
) δ 152.3, 147.3, 146.5, 134.9, 132.9,
29.8, 128.3, 126.0, 120.0, 108.1, 107.2, 100.9, 68.9, 52.1; HRMS (ESI-TOF) m/z Calcd for C16
2
3
1
6
H
15
N
2
O
3

HETEROCYCLES, Vol. 92, No. 12, 2016
2189
+
-1
2
83.1082 [M + H] ; Found 283.1088; IR (νmax, cm ): 3320, 1604; Anal. Calcd for C16
H
14
N
2
3
O : C, 68.07;
H, 5.00; N, 9.92%. Found: C, 67.67; H, 4.67; N, 9.79%.
5
-(2-Methoxyphenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine
(6w)
and
5
-(4-methoxyphenyl)-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6b). General procedure E was
followed starting from 9 (110 mg, 0.44 mmol) using anisole as the nucleophile and stirring at 100 °C for
.5 h. Purification by silica flash column chromatography (20% to 40% EtOAc in n-heptane) and
2
lyophilization afforded compound 6w (23 mg, 20% yield) as an amorphous yellow solid and compound
1
6
2
7
1
1
C
C
b (79 mg, 67% yield) as an amorphous pink solid; 6w: H NMR (400 MHz, DMSO-d
6
) δ 7.77 – 7.67 (m,
H), 7.53 (d, J = 3.9 Hz, 1H), 7.50 – 7.39 (m, 3H), 7.33 – 7.25 (m, 1H), 7.22 (dd, J = 7.5, 1.6 Hz, 1H),
.04 (dd, J = 8.2, 0.8 Hz, 1H), 7.01 – 6.92 (m, 1H), 4.97 (q, J = 3.6 Hz, 1H), 3.92 (dd, J = 10.8, 3.5 Hz,
1
3
H), 3.84 (s, 3H), 3.78 (dd, J = 10.8, 3.6 Hz, 1H); C NMR (101 MHz, DMSO-d ) δ 155.9, 152.5, 133.0,
6
29.8, 128.6, 128.4, 128.3, 127.3, 125.9, 120.2, 110.7, 67.0, 55.5, 47.2; HRMS (ESI-TOF) m/z Calcd for
+
-1
16
H
17
N
2
O
2
269.1290 [M + H] ; Found 269.1287; IR (νmax, cm ): 3382, 1603; Anal. Calcd for
16
H
16
N
2
O
2
: C, 71.62; H, 6.01; N, 10.44%. Found: C, 71.51; H, 5.97; N, 9.99%.
5
-Allyl-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (6x). To a solution of 10 (250 mg, 1.21 mmol) in
DCM (5 mL) at 0 °C under nitrogen atmosphere allyltrimethylsilane (693 mg, 6.06 mmol) and BF ·OEt
860 mg, 6.06 mmol) were added. The mixture was allowed to come to rt and stirred for 20 h. It was
poured out onto sat. aq. sodium bicarbonate, the layers were separated, the organic layer was dried using
3
2
(
Na
2
SO
4
, concentrated and purified by silica flash column chromatography (0% to 50% EtOAc in
1
n-heptane) to afford compound 6x (156 mg, 64% yield) as an oil that solidified upon standing; H NMR
(
400 MHz, CDCl
3
) δ 7.67 – 7.55 (m, 2H), 7.47 – 7.31 (m, 3H), 5.91 – 5.73 (m, 1H), 5.25 – 5.21 (m, 1H),
5
2
3
3
1
1
.21 – 5.17 (m, 1H), 4.92 (s, 1H), 4.18 – 4.02 (m, 1H), 3.73 – 3.54 (m, 2H), 2.50 – 2.36 (m, 1H), 2.33 –
1
3
.17 (m, 1H); C NMR (101 MHz, CDCl
3
) δ 152.5, 133.0, 133.0, 130.2, 128.7, 125.9, 119.3, 67.6, 48.8,
+
7.5; HRMS (ESI-TOF) m/z Calcd for C12
H
15
N
2
O 203.1184 [M + H] ; Found 203.1182; IR (νmax, cm-1):
323, 1607; Anal. Calcd for C12
3.65%.
H
14
2
N O: C, 71.26; H, 6.98; N, 13.85%. Found: C, 71.09; H, 7.20; N,
-Phenyl-2-(3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazin-5-yl)ethan-1-one (6y). 1-Phenyl-1-trimethyl-
siloxyethylene (242 mg, 1.26 mmol) was slowly added to a suspension of 10 (200 mg, 0.97 mmol) and
scandium trifluoromethanesulfonate (48 mg, 0.10 mmol) in DCM (5 mL) at 0 °C under an argon
atmosphere. The mixture was allowed to come to rt and stirred for 24 h. Additional
1-phenyl-1-trimethylsiloxyethylene (242 mg, 1.26 mmol) was added and stirring was continued for 24 h.
The mixture was concentrated under reduced pressure and the residue was purified by silica flash
chromatography (10% to 60% EtOAc in n-heptane) to afford compound 6y (90 mg, 33% yield) as a gum;
1H NMR (400 MHz, CDCl
) δ 8.05 – 7.93 (m, 2H), 7.66 – 7.56 (m, 3H), 7.55 – 7.45 (m, 2H), 7.45 – 7.33
3

2190
HETEROCYCLES, Vol. 92, No. 12, 2016
(m, 3H), 5.65 (s, 1H), 4.38 – 4.22 (m, 1H), 4.12 – 3.97 (m, 2H), 3.57 (dd, J = 18.0, 9.8 Hz, 1H), 3.28 (dd,
1
3
J = 18.0, 3.3 Hz, 1H); C NMR (101 MHz, CDCl
3
) δ 198.9, 153.1, 136.5, 133.9, 132.7, 130.4, 128.9,
281.1290 [M + H]+;
: C, 72.84; H, 5.76; N,
1
28.8, 128.2, 126.0, 67.3, 46.4, 43.0; HRMS (ESI-TOF) m/z Calcd for C17
H
17
N
2
O
2
-1
Found 281.1293; IR (νmax, cm ): 3207, 1684, 1608; Anal. Calcd for C17
H
16
N
2
O
2
9
.99%. Found: C, 73.08; H, 5.75; N, 10.02%.
5-(Furan-2-yl)-4-methyl-3-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (14a). General procedure E was
followed starting from 13a (198 mg, 0.74 mmol) using furan as the nucleophile and stirring at 70 °C for 4
h. Purification by silica flash column chromatography (0% to 50% EtOAc in n-heptane), followed by
1
basic preparative HPLC afforded compound 14a (105 mg, 58% yield) as an amorphous solid; H NMR
(
400 MHz, DMSO-d
J = 3.9 Hz, 1H), 4.15 (dd, J = 11.3, 4.2 Hz, 1H), 4.03 (dd, J = 11.3, 3.7 Hz, 1H), 2.63 (s, 3H); C NMR
101 MHz, DMSO-d ) δ 156.1, 151.6, 142.8, 132.5, 129.4, 128.6, 128.4, 110.6, 107.9, 66.4, 54.3, 37.8,
HRMS (ESI-TOF) m/z Calcd for C14
Anal. Calcd for C14 : C, 69.41; H, 5.82; N, 11.56%. Found: C, 69.04; H, 5.73; N, 11.69%.
-(Furan-2-yl)-3,4-diphenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (14b). General procedure E was
followed starting from 13b (171 mg, 0.52 mmol) using furan as the nucleophile and stirring at 70 °C for
6
) δ 7.69 (dd, J = 1.8, 0.9 Hz, 1H), 7.55 – 7.34 (m, 5H), 6.53 – 6.43 (m, 2H), 4.71 (t,
1
3
(
6
+
-1
H
15
N
2
O 243.1133 [M + H] ; Found 243.1139; IR (νmax, cm ): 1591;
2
H
14
N O
2 2
5
20 h. Purification by silica flash column chromatography (0% to 50% EtOAc in n-heptane), followed by
1
basic preparative HPLC afforded compound 14b (108 mg, 68% yield) as an amorphous solid; H NMR
(
400 MHz, DMSO-d
6
) δ 7.69 (dd, J = 1.8, 0.9 Hz, 1H), 7.55 – 7.34 (m, 5H), 6.53 – 6.43 (m, 2H), 4.71 (t,
1
3
J = 3.9 Hz, 1H), 4.15 (dd, J = 11.3, 4.2 Hz, 1H), 4.03 (dd, J = 11.3, 3.7 Hz, 1H), 2.63 (s, 3H); C NMR
(
101 MHz, DMSO-d
6
) δ 151.9, 151.0, 144.9, 142.7, 133.5, 129.0, 128.2, 128.1, 125.1, 125.0, 110.7, 107.7,
+
6
6.3, 55.4; HRMS (ESI-TOF) m/z Calcd for C19
H
17
N
2
O
2
305.1290 [M + H] ; Found 305.1286; IR (νmax
,
-
1
cm ): 1588; Anal. Calcd for C19
.17%.
S)-2-(Aminooxy)-1-phenylethan-1-amine (16). At 0 °C, diisopropyl azodicarboxylate (1.79 g, 8.85
mmol, 1.72 mL) was added to a solution of tert-butyl (S)-(2-hydroxy-1-phenylethyl)carbamate 15 (2.00 g,
.43 mmol), N-hydroxyphthalimide (1.44 g, 8.85 mmol) and triphenylphosphine (2.32 g, 8.85 mmol) in
H
16
N
2
O : C, 74.98; H, 5.30; N, 9.20%. Found: C, 74.80; H, 5.27; N,
2
9
(
8
THF (50 mL). The mixture was stirred at rt for 1 h, concentrated and the residue was purified by silica
flash chromatography (5% to 25% EtOAc in n-heptane) to obtain a solid. Further purification by silica
flash
S)-(2-((1,3-dioxoisoindolin-2-yl)oxy)-1-phenylethyl)carbamate (3.01 g, 93%) as a solid; H NMR (400
MHz, CDCl ) δ 7.83 – 7.77 (m, 2H), 7.77 – 7.70 (m, 2H), 7.42 – 7.36 (m, 2H), 7.34 – 7.27 (m, 2H), 7.25
7.16 (m, 1H), 5.92 (s, 1H), 5.04 (s, 1H), 4.60 – 4.41 (m, 2H), 1.44 (s, 9H); C NMR (101 MHz, CDCl
δ 163.5, 155.6, 138.6, 134.7, 128.8, 128.7, 127.7, 126.6, 123.7, 80.4, 80.0, 28.5. Hydrazine
chromatography
(0%
to
2%
MeOH
in
DCM)
afforded
tert-butyl
1
(
3
1
3
–
3
)

HETEROCYCLES, Vol. 92, No. 12, 2016
2191
monohydrate (0.433 g, 8.66 mmol, 0.422 mL) was added to a suspension of tert-butyl
S)-(2-((1,3-dioxoisoindolin-2-yl)oxy)-1-phenylethyl)carbamate (3.01 g, 7.87 mmol) in EtOH (25 mL)
(
and the mixture was stirred at rt for 15 min. The solids were filtered off, the filtrate was concentrated and
the residue was purified by silica flash column chromatography (1% to 6% MeOH in DCM) to obtain the
crude product. Further purification by silica flash column chromatography (20% to 100% EtOAc in
1
n-heptane) afforded tert-butyl (S)-(2-(aminooxy)-1-phenylethyl)carbamate (1.60 g, 80%) as a solid; H
NMR (400 MHz, DMSO-d
6
) as a mixture of rotamers δ 7.42 – 7.26 (m, 5H), 7.26 – 7.18 (m, 1H), 6.04 (s,
2H), 4.89 – 4.75 (m, 0.9H), 4.75 – 4.59 (m, 0.1H), 3.63 (dd, J = 10.6, 8.3 Hz, 1H), 3.55 (dd, J = 10.7, 5.5
1
3
Hz, 1H), 1.47 – 1.13 (m, 9H); C NMR (101 MHz, DMSO-d
2.8, 28.2; HRMS (ESI-TOF) m/z Calcd for C13
hydrochloric acid in EtOAc (10 mL) was added to
S)-(2-(aminooxy)-1-phenylethyl)carbamate (1.55 g, 6.14 mmol) in EtOAc (10 mL). The mixture was
stirred at rt for 1 h and concentrated. The residue was dissolved in MeOH (20 mL), K CO (2.0 g, 18.4
mmol) was added and the mixture was stirred at rt for 1 h. The solids were filtered off, the filtrate was
6
) δ 155.2, 141.3, 128.1, 126.8, 126.8, 77.8,
+
5
H
21
N
2
O
3
253.1552 [M + H] ; Found 253.1569. Saturated
a
solution of tert-butyl
(
2
3
concentrated and purified by silica flash column chromatography (10% (7M NH in MeOH) in DCM) to
3
1
afford compound 16 (764 mg, 82%) as an oil; H NMR (400 MHz, CDCl
3
) δ 7.39 – 7.32 (m, 4H), 7.29 –
7.25 (m, 1H), 4.29 (dd, J = 8.7, 4.0 Hz, 1H), 3.79 (dd, J = 10.3, 4.0 Hz, 1H), 3.67 (dd, J = 10.3, 8.7 Hz,
1
3
1
H); C NMR (101 MHz, CDCl ) δ 142.6, 128.6, 127.5, 126.9, 81.9, 54.5; HRMS (ESI-TOF) m/z Calcd
3
+
for C
8
H
13
N O 153.1028 [M + H] ; Found 153.1038.
2
General procedure F for the synthesis of substituted 5,6-dihydro-4H-[1,2,4]oxadiazines via condensation
of a diamine with an imidate. A 0.25 M solution of a diamine and an imidate (1 equiv.) was stirred in
acetic acid at rt for 16 h, followed by heating to 100 °C for the indicated time. The mixture was
concentrated, dissolved in DCM, washed with sat. NaHCO
crude product was purified as described. When the diamine was a HCl salt, the free base was first
prepared by stirring the compound in MeOH with K CO (3 equiv.) for 30 min, followed by filtration and
concentration of the filtrate, assuming quantitative yield.
3
, dried using Na
2
SO , concentrated and the
4
2
3
(S)-3,5-Diphenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (S-6a). General procedure F was followed using
(S)-2-(aminooxy)-1-phenylethan-1-amine 16 (93 mg, 0.61 mmol) and ethyl benzimidate hydrochloride
and stirring at 100 °C for 2 h. Purification by silica flash column chromatography (50% EtOAc in
2
3.5
n-heptane) afforded compound S-6a (123 mg, 84% yield) as a crystalline solid; mp 129 – 131 °C; [α]
109.3 (c 1, MeOH); Chiral HPLC: t : 13.31 min, 100% (column: Chiralpak AD-H, 250 x 4.6 mm, 5 μm,
eluent: 20% EtOH in heptane, flow: 1 mL/min, temp: 25 °C).
S)-3-Methyl-5-phenyl-5,6-dihydro-4H[1,2,4]oxadiazine (S-18b). General procedure F was followed
using (S)-2-(aminooxy)-1-phenylethan-1-amine 16 (161 mg, 1.06 mmol) and ethyl acetimidate
D
=
R
(

2192
HETEROCYCLES, Vol. 92, No. 12, 2016
hydrochloride, additional heating was not required. Purification by silica flash column chromatography
(1% to 6% MeOH in DCM) afforded compound S-18b (152 mg, 82% yield) as a solid; mp 154 –
1
1
3
1
55.5 °C; H NMR (400 MHz, CDCl
3
) δ 7.41 – 7.25 (m, 5H), 4.89 (s, 1H), 4.62 – 4.46 (m, 1H), 4.20 –
13
.99 (m, 1H), 3.60 (dd, J = 11.1, 7.2 Hz, 1H), 1.95 (s, 3H); C NMR (101 MHz, CDCl
29.0, 128.6, 126.8, 69.5, 54.2, 18.4; HRMS (ESI-TOF) m/z Calcd for C10
O 177.1028 [M + H]+;
O: C, 70.28; H, 5.48; N, 17.56%.
3
) δ 151.3, 139.0,
H
13
N
2
-1
Found 177.1024; IR (νmax, cm ): 3198, 1615; Anal. Calcd for C10
Found: C, 70.58; H, 5.45; N, 18.03%; [α] 24
60.0 (c 1.1, MeOH).
S)-3-Cyclohexyl-5-phenyl-5,6-dihydro-4H-[1,2,4]oxadiazine (S-18c). General procedure F was
H
12
N
2
D
(
followed using (S)-2-(aminooxy)-1-phenylethan-1-amine 16 (177 mg, 1.16 mmol) and ethyl
cyclohexanecarbimidate hydrochloride and stirring at 100 °C for 30 min. Purification by silica flash
column chromatography (10% to 60% EtOAc in n-heptane) afforded compound S-18c (258 mg, 91%
1
yield) as a solid; mp 105 – 106 °C; H NMR (400 MHz, CDCl
3
) δ 7.46 – 7.33 (m, 3H), 7.33 – 7.29 (m,
2H), 4.64 – 4.54 (m, 1H), 4.51 (s, 1H), 4.28 – 4.04 (m, 1H), 3.60 (dd, J = 11.1, 7.5 Hz, 1H), 2.23 (tt, J =
1
3
1
1.9, 3.4 Hz, 1H), 2.06 – 1.93 (m, 2H), 1.93 – 1.79 (m, 2H), 1.78 – 1.69 (m, 1H), 1.54 – 1.14 (m, 5H); C
NMR (101 MHz, CDCl
3
) δ 158.0, 139.3, 129.1, 128.5, 126.8, 69.9, 54.2, 42.0, 31.0, 30.8, 26.22, 26.18,
O 245.1654 [M + H] ; Found 245.1657; IR (νmax, cm-1):
+
2
3
1
6.0; HRMS (ESI-TOF) m/z Calcd for C15
229, 1609; Anal. Calcd for C15
H
21
N
2
H
20
N
2
O: C, 73.74; H, 8.25; N, 11.47%. Found: C, 73.50; H, 8.47; N,
24
1.54%; [α]
D
47.6 (c 1, MeOH).
(S)-5-Phenyl-3-(pyridin-2-yl)-5,6-dihydro-4H-[1,2,4]oxadiazine (S-18d). General procedure F was
followed using (S)-2-(aminooxy)-1-phenylethan-1-amine 16 (161 mg, 1.06 mmol) and methyl
picolinimidate and stirring at 100 °C for 2 h. Purification by silica flash column chromatography (10% to
6
0% EtOAc in n-heptane) afforded compound S-18d (215 mg, 85% yield) as a solid; mp 105 – 106.5 °C;
1H NMR (400 MHz, CDCl
) δ 8.51 (d, J = 4.7 Hz, 1H), 8.11 (d, J = 8.0 Hz, 1H), 7.75 (td, J = 7.8, 1.7 Hz,
H), 7.47 – 7.28 (m, 6H), 6.94 (s, 1H), 4.84 – 4.66 (m, 1H), 4.40 – 4.24 (m, 1H), 3.74 (dd, J = 10.9, 7.0
3
1
13
Hz, 1H); C NMR (101 MHz, CDCl
3
) δ 150.2, 148.7, 148.2, 139.0, 136.9, 129.1, 128.5, 126.9, 124.9,
+
1
20.3, 70.2, 53.6; HRMS (ESI-TOF) m/z Calcd for C14
H
14
N
3
O 240.1137 [M + H] ; Found 240.1138; IR
-1
(
ν
max, cm ): 3398, 1618; Anal. Calcd for C14
.45; N, 17.83%; [α] 24
145.5 (c 1.1, MeOH).
-(Aminooxy)propan-1-amine dihydrochloride (20b). tert-Butyl (2-(aminooxy)propyl)carbamate21
H
13
N
3
O: C, 70.28; H, 5.48; N, 17.56%. Found: C, 70.58; H,
5
2
D
(
500 mg, 2.63 mmol) was added to a 4 M solution of HCl in EtOAc (10 mL) and stirred for 1 h at rt.
Evaporation of the reaction mixture afforded compound 20b (420 mg, 98%) as a solid; mp 194 – 195 °C
1
(
decomp.); H NMR (400 MHz, DMSO-d
6
) δ 11.20 (s, 3H), 8.37 (s, 3H), 4.62 – 4.44 (m, 1H), 3.07 (m,
) δ 77.21, 41.23, 16.45; HRMS
2
H), 1.33 (d, J = 6.3 Hz, 3H); 13C NMR (101 MHz, DMSO-d
6
+
(ESI-TOF) m/z Calcd for C
3
H
11
N O 91.0864 [M + H] ; Found 91.0871.
2

HETEROCYCLES, Vol. 92, No. 12, 2016
2193
(1R,2S)-2-(Aminooxy)cyclohexan-1-amine
(20e).
To
a
solution
of
tert-butyl
((1R,2R)-2-hydroxycyclohexylcarbamate (1.0 g, 4.64 mmol) and N-hydroxyphthalimide (909 mg, 5.57
mmol) in dry THF (70 mL) was added triphenylphosphine (1.83 g, 6.96 mmol) and diisopropyl
azodicarboxylate (1.35 mL, 6.96 mmol) and the mixture was stirred at rt for 3 h. The mixture was diluted
with water (100 mL) and extracted with DCM (3 × 100 mL). The combined organic layers were washed
with brine, dried over Na
2
SO , concentrated and purified by silica flash column chromatography (40%
4
EtOAc in n-heptane) to afford tert-butyl ((1R,2S)-2-((1,3-dioxoisoindolin-2-yl)oxy)cyclohexyl)carbamate
1
(
1.18 g, 71%) as a solid; H NMR (400 MHz, CDCl
3
) δ 7.88 – 7.84 (m, 2H), 7.80 – 7.75 (m, 2H), 5.85 (br
d, J = 7.0 Hz, 1H), 4.36 (s, 1H), 3.69 (br s, 1H), 2.27 – 2.23 (m, 1H), 1.97 – 1.69 (m, 4H), 1.60 – 1.35 (m,
1
3
1
2H); C NMR (101 MHz, CDCl
3
) δ 164.2, 155.7, 134.7, 129.0, 123.7, 87.2, 79.2, 51.7, 29.4, 28.5, 27.6,
2
4.4, 19.6. To a solution of tert-butyl ((1R,2S)-2-((1,3-dioxoisoindolin-2-yl)oxy)cyclohexyl)carbamate
(
450 mg, 1.25 mmol) in DCM (40 mL) was added TFA (20 mL) and the mixture was stirred at rt for 3 h.
The reaction mixture was concentrated and the residue was coevaporated with toluene (3 × 25 mL), DCM
25 mL) and Et O (25 mL) to give an off-white foam as residue. This was dissolved in EtOH (35 mL),
(
2
hydrazine monohydrate (0.47 mL, 9.6 mmol) was added and the mixture was stirred at rt for 16 h. The
solids were filtered off, the filtrate was concentrated on silica and purified by silica flash column
1
chromatography (10% (7M NH
400 MHz, CDCl
H), 1.38 – 1.31 (m, 2H); 13C NMR (101 MHz, CDCl
3
in MeOH) in DCM) to afford 20e (116 mg, 65%) as an oil; H NMR
(
3
) δ 3.70 (dt, J = 6.9, 3.2 Hz, 1H), 3.23 (m, 1H), 1.92 – 1.86 (m, 1H), 1.72 – 1.44 (m,
) δ 82.2, 50.5, 29.8, 26.5, 22.2, 21.6; HRMS
O 131.1184 [M + H] ; Found 131.1195.
1R,2R)-2-(Aminooxy)cyclohexan-1-amine (20f). To
(1R,2S)-2-hydroxycyclohexylcarbamate (0.5 g, 2.32 mmol) and N-hydroxyphthalimide (568 mg, 3.48
5
3
+
(
(
(
ESI-TOF) m/z Calcd for C
6
H
15
N
2
a
solution
of
tert-butyl
mmol) in dry THF (40 mL) was added triphenylphosphine (914 mg, 3.48 mmol) and diisopropyl
azodicarboxylate (0.67 mL, 3.48 mmol) and the mixture was stirred at rt for 72 h. The mixture was
diluted with water (70 mL) and extracted with DCM (3 × 70 mL). The combined organic layers were
washed with brine (70 mL), dried over Na
chromatography (45% EtOAc
2
SO
4
, concentrated and purified by silica flash column
in
n-heptane)
to
afford
tert-butyl
1
(
(1R,2R)-2-((1,3-dioxoisoindolin-2-yl)oxy)cyclohexyl)carbamate (563 mg, 67%) as a solid; H NMR
(
400 MHz, CDCl
3
) δ 7.86 – 7.82 (m, 2H), 7.78 – 7.74 (m, 2H), 5.61 (br s, 1H), 3.98 – 3.91 (m, 1H), 3.64
–
–
3
3.57 (m, 1H), 2.41 (br d, J = 10.5 Hz, 1H), 2.19 – 2.15 (m, 1H), 1.83 – 1.60 (m, 3H), 1.44 (s, 9H), 1.40
13
1.18 (m, 3H); C NMR (101 MHz, CDCl
0.5, 28.6, 23.9, 23.7.
3
) δ 164.3, 155.9, 134.7, 128.9, 123.7, 88.7, 79.3, 53.2, 31.8,
To solution of tert-butyl
a
((1R,2R)-2-((1,3-dioxoisoindolin-2-yl)oxy)cyclohexyl)carbamate (540 mg, 1.49 mmol) in DCM (40 mL)
was added TFA (20 mL) and the mixture was stirred at rt for 1 h. The reaction mixture was concentrated

2194
HETEROCYCLES, Vol. 92, No. 12, 2016
and the residue was coevaporated with toluene (3 × 25 mL), DCM (25 mL) and Et O (25 mL) to give an
2
off-white foam as residue. This was dissolved in EtOH (35 mL), hydrazine monohydrate (0.6 mL, 12.3
mmol) was added and the mixture was stirred at rt for 16 h. The solids were filtered off, the filtrate was
concentrated on silica and purified by silica flash column chromatography (10% (7M NH in MeOH) in
3
1
DCM) to afford 20f (115 mg, 55%) as an oil; H NMR (400 MHz, CDCl
3
) δ 3.15 (ddd, J = 10.2, 9.3, 4.2
Hz, 1H), 2.62 (ddd, J = 10.8, 9.3, 4.4 Hz, 1H), 2.20 – 2.17 (m, 1H), 1.89 – 1.84 (m, 1H), 1.76 – 1.73 (m,
1
3
1
2
1
H), 1.67 – 1.63 (m, 1H), 1.27 – 1.11 (m, 4H); C NMR (101 MHz, CDCl ) δ 89.0, 53.7, 34.3, 29.6, 24.8,
3
+
4.5; HRMS (ESI-TOF) m/z Calcd for C
6
H
15
N
2
O 131.1184 [M + H] ; Found 131.1196.
-(Aminooxy)-2-methylpropan-2-amine dihydrochloride (20j). Under an argon atmosphere, potassium
bis(trimethylsilyl)amide (1 M in THF, 29.8 mL, 29.8 mmol) was added to a solution of acetone oxime
2.18 g, 29.8 mmol) in dry DMF (100 mL). solution of
,4-dimethyl-2-(trifluoromethyl)-4,5-dihydrooxazole22 (3.33 g, 19.9 mmol) in dry DMF (25 mL) was
added and the mixture was heated at 80 °C for 2 h. The mixture was quenched with saturated aqeuous
NH Cl and extracted with EtOAc twice. The combined organic layers were washed with water, brine,
(
A
4
4
dried over Na
to
2
SO
4
, concentrated and the residue was purified by silica flash column chromatography (5%
EtOAc in n-heptane) to afford
25%
2,2,2-trifluoro-N-(2-methyl-1-((propan-2-ylideneamino)oxy)propan-2-yl)acetamide (3.45 g, 68%) as a
1
pale yellow oil; H NMR (400 MHz, CDCl
3
) δ 8.00 (s, 1H), 3.93 (s, 2H), 1.89 (s, 3H), 1.88 (s, 3H), 1.43
s, 6H). A solution of 2,2,2-trifluoro-N-(2-methyl-1-((propan-2-ylideneamino)oxy)propan-2-yl)acetamide
3.45 g, 13.5 mmol) and sodium hydroxide (2.5 g, 42 mmol) in MeOH (75 mL) and water (75 mL) was
(
(
heated at 55 °C for 16 h in a closed flask. The mixture was extracted with DCM (4 × 75 mL). The
combined organic layers were dried over Na
2
SO
4
and concentrated to afford propan-2-one
1
O-(2-amino-2-methylpropyl) oxime (1.95 g, 95%) as an oil; H NMR (400 MHz, CDCl
3
) δ 3.82 (s, 2H),
) δ 154.7, 83.4, 53.6, 50.9, 50.4, 27.5,
2.0, 15.7. A solution of propan-2-one O-(2-amino-2-methylpropyl) oxime (1.95 g, 12.8 mmol) in 2 M
1
3
1
.89 (s, 3H), 1.88 (s, 3H), 1.13 (s, 6H); C NMR (101 MHz, CDCl
3
2
aqueous HCl (100 mL) was heated at 90 °C for 16 h. The mixture was concentrated under reduced
1
pressure and triturated from EtOH (30 mL) to afford 20j (1.30 g, 57%) as a solid; H NMR (400 MHz,
DMSO-d
-((Aminooxy)methyl)cyclopentan-1-amine (20k). To a solution of (1-aminocyclopentyl)methanol
1.60 g, 13.9 mmol) and N,N-diisopropylethylamine (3.59 g, 27.8 mmol) in DCM (75 mL) at 0 °C,
trifluoroacetic anhydride (3.79 g, 18.06 mmol) was slowly added and the resulting mixture was stirred at
rt for 90 min. Saturated aqueous NaHCO was added, the layers were separated and the aqueous layer was
extracted with DCM. The combined organic layers were dried over Na SO , concentrated under reduced
pressure and the residue was purified by silica flash column chromatography (10% to 50% EtOAc in
6
) δ 11.28 (bs, 3H), 7.91 (bs, 3H), 4.08 (s, 2H), 1.31 (s, 6H), spectral data identical to literature.23
1
(
3
2
4

HETEROCYCLES, Vol. 92, No. 12, 2016
2195
n-heptane) to obtain 2,2,2-trifluoro-N-(1-(hydroxymethyl)cyclopentyl)acetamide (2.68 g, 91% yield) as a
1
solid; H NMR (400 MHz, CDCl
3
) δ 6.42 (s, 1H), 3.71 (s, 2H), 2.49 (s, 1H), 2.00 – 1.75 (m, 6H), 1.75 –
) δ 157.3 (q, J = 36 Hz), 115.9 (q, J = 288 Hz), 67.0, 66.7, 34.9,
13
1
2
2
.61 (m, 2H); C NMR (101 MHz, CDCl
3
4.3. At 0 °C, diisopropyl azodicarboxylate (2.69 g, 13.3 mmol) was added to a solution of
,2,2-trifluoro-N-(1-(hydroxymethyl)cyclopentyl)acetamide (2.68 g, 12.7 mmol) and triphenylphosphine
(
3.50 g, 13.3 mmol) in DCM (100 mL). The mixture was stirred at rt for 30 min, concentrated, pentane
100 mL) was added and the mixture was stirred vigorously for 1 h. The solids were filtered off, washed
(
with pentane and concentrated to afford 2-(trifluoromethyl)-3-oxa-1-azaspiro[4.4]non-1-ene as a yellow
oil, which was used crude in the next step. Under an argon atmosphere potassium bis(trimethylsilyl)amide
(
1 M in THF, 18.1 mL, 18.1 mmol) was added to a solution of acetone oxime (1.32 g, 18.1 mmol) in dry
DMF (40 mL). A solution of 2-(trifluoromethyl)-3-oxa-1-azaspiro[4.4]non-1-ene from the previous step
in dry DMF (20 mL) was added and the mixture was heated at 80 °C for 2 h. The mixture was quenched
with saturated aqeuous NH
water, brine, dried over Na
chromatography (5%
4
Cl and extracted with EtOAc. The combined organic layer was washed with
SO , concentrated and the residue was purified by silica flash column
to 25% EtOAc in n-heptane) to afford
2
4
2,2,2-trifluoro-N-(1-(((propan-2-ylideneamino)oxy)methyl)cyclopentyl)acetamide (2.83 g, 71% over 2
1
steps) as a pale yellow oil; H NMR (400 MHz, CDCl
3
) δ 7.76 (s, 1H), 3.98 (s, 2H), 2.19 – 2.07 (m, 2H),
1
3
1
.99 – 1.89 (m, 2H), 1.88 (s, 3H), 1.87 (s, 3H), 1.80 – 1.68 (m, 2H), 1.67 – 1.54 (m, 2H); C NMR (101
MHz, CDCl
3
) δ 156.40, 156.1 (q, J = 36 Hz), 116.0 (q, J = 289 Hz), 75.9, 66.1, 33.3, 25.0, 21.7, 15.6;
+
HRMS (ESI-TOF) m/z Calcd for C11
H
17
F
3
N
2
O
2
Na 289.1140 [M + Na] ; Found 289.1144. A solution of
2
,2,2-trifluoro-N-(1-(((propan-2-ylideneamino)oxy)methyl)cyclopentyl)acetamide (2.23 g, 8.38 mmol)
and sodium hydroxide (1.68 g, 41.9 mmol) in MeOH (75 mL) and water (75 mL) was heated at 55 °C for
6 h in a closed flask. The mixture was extracted with DCM (4 × 75 mL), the combined organic layers
were dried over Na SO and concentrated to afford propan-2-one O-((1-aminocyclopentyl)methyl) oxime
1
2
4
1
(
1.42 g, 99%) as an oil; H NMR (400 MHz, CDCl ) δ 3.92 (s, 2H), 1.88 (s, 3H), 1.87 (s, 3H), 1.84 – 1.73
3
1
3
(
m, 2H), 1.73 – 1.57 (m, 4H), 1.49 – 1.38 (m, 2H); C NMR (101 MHz, CDCl
4.5, 21.8, 15.6; HRMS (ESI-TOF) m/z Calcd for C
3
) δ 154.6, 81.7, 61.5, 38.0,
+
2
9
H
19
N
2
O 171.1497 [M + H] ; Found 171.1492. A
solution of propan-2-one O-((1-aminocyclopentyl)methyl) oxime (1.22 g, 7.15 mmol) in 2 M aqueous
hydrochloric acid (100 mL) was heated at 90 °C for 16 h. The mixture was concentrated under reduced
pressure and the residue was purified by silica flash chromatography (5% to 10% (7M NH in MeOH) in
3
1
DCM) to afford 20k (724 mg, 79%) as an oil; H NMR (400 MHz, CDCl
3
) δ 3.58 (s, 2H), 1.88 – 1.69 (m,
1
3
2
H), 1.69 – 1.51 (m, 4H), 1.51 – 1.34 (m, 2H); C NMR (101 MHz, CDCl ) δ 84.9, 61.4, 38.3, 24.5;
3
+
HRMS (ESI-TOF) m/z Calcd for C
6
H
15
N
2
O 131.1184 [M + H] ; Found 131.1188.